{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":238,"total_is_capped":false,"direct_labels_cover":1,"predictions_cover":238,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"63d93883b4e9","filters":{"venue":"The Journal of Clinical Pharmacology"}},"results":[{"id":"W1981726399","doi":"10.1177/0091270006292126","title":"The Anticholinergic Drug Scale as a Measure of Drug‐Related Anticholinergic Burden: Associations With Serum Anticholinergic Activity","year":2006,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Intensive Care Unit Cognitive Disorders","field":"Medicine","cited_by":662,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Baycrest Hospital; University of Toronto","funders":"National Center for Research Resources; National Institute of Nursing Research; National Institute of Mental Health; National Institute on Aging","keywords":"Anticholinergic; Delirium; Drug; Medicine; Linear regression; Internal medicine; Regression analysis; Adverse effect; Pharmacology; Psychiatry; Statistics","retraction":null,"screen_n_in":null,"score":{"opus":0.01973300900122983,"gpt":0.3669907101671299,"spread":0.3472577011659001,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005595629,0.000367473,0.001376584,0.0002269632,0.0003611552,0.00002380572,0.0005687517,0.0002498491,0.0001328142],"category_scores_gemma":[0.00463709,0.0001965265,0.0006761977,0.0008220138,0.001417206,0.0001751792,0.0001067346,0.002508411,0.00003418266],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008461794,"about_ca_system_score_gemma":0.0008766207,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001464748,"about_ca_topic_score_gemma":0.00007381591,"domain_scores_codex":[0.9937933,0.002194551,0.002166865,0.0002808154,0.0009642635,0.000600212],"domain_scores_gemma":[0.9802523,0.005134195,0.002589989,0.0003700588,0.01139663,0.0002568337],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.05654784,0.01084367,0.2814147,0.0003329387,0.01495617,0.001875013,0.003586613,0.01551357,0.2126888,0.0009397719,0.3896297,0.01167117],"study_design_scores_gemma":[0.07249356,0.006303926,0.7817392,0.00113131,0.02135496,0.003903408,0.007516698,0.007275254,0.07614117,0.003025977,0.01765517,0.001459379],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9465657,0.001020205,0.000062959,0.04656776,0.001663286,0.0005694989,0.00002567156,0.00003048205,0.003494454],"genre_scores_gemma":[0.9892776,0.001042095,0.00008333817,0.005957408,0.00148957,0.00000434696,0.000009006651,0.00005976492,0.002076855],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5003245,"threshold_uncertainty_score":0.9997928,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2109918996","doi":"10.1002/j.1552-4604.2002.tb05998.x","title":"Cannabidiol: An Overview of Some Pharmacological Aspects","year":2002,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":506,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Wilfrid Laurier University","funders":"","keywords":"Cannabidiol; Cannabinoid; Pharmacology; Cannabis; Endocannabinoid system; Cannabinoid receptor; Antipsychotic; Anandamide; Mechanism of action; Chemistry; Tetrahydrocannabinol; Mechanism (biology); Medicine; Receptor; Schizophrenia (object-oriented programming); Psychiatry; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.4393587792722187,"gpt":0.5887265220845699,"spread":0.1493677428123512,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.007841162,0.0005149425,0.006080084,0.0003689417,0.00008918829,0.00001300081,0.001294096,0.0007743227,0.004810943],"category_scores_gemma":[0.0008154858,0.0002653645,0.002632719,0.0005189182,0.001014097,0.0001425978,0.0002870274,0.00461794,0.00007535836],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001678667,"about_ca_system_score_gemma":0.002418881,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001312936,"about_ca_topic_score_gemma":0.000001598067,"domain_scores_codex":[0.989,0.004429283,0.004583557,0.0003593172,0.0009788251,0.0006490257],"domain_scores_gemma":[0.993438,0.0009929367,0.003373493,0.0004705059,0.0007684357,0.0009566428],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009176309,0.001995466,0.000008111644,0.006426545,0.002139997,0.0007917351,0.00003724386,0.000003401485,0.00006781657,0.0001118327,0.3592253,0.6282749],"study_design_scores_gemma":[0.002894253,0.004948062,0.00009456357,0.001905822,0.01149446,0.002527883,0.00001469606,0.00002552952,0.00003931695,0.0001404767,0.9756888,0.0002261231],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001490709,0.988686,0.000001492225,0.004709995,0.003371569,0.001110906,0.00003087123,0.00001620627,0.0005822823],"genre_scores_gemma":[0.0002291999,0.9866498,0.00002635511,0.002457029,0.008099289,0.00002195762,0.000006774922,0.00007444545,0.002435172],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6280488,"threshold_uncertainty_score":0.9999799,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2050102690","doi":"10.1177/0091270007299930","title":"Nuclear Receptors and the Regulation of Drug‐Metabolizing Enzymes and Drug Transporters: Implications for Interindividual Variability in Response to Drugs","year":2007,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":377,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"London Health Sciences Centre; Western University","funders":"National Institute of General Medical Sciences","keywords":"Drug; Pharmacology; Transporter; Drug response; Drug metabolism; Receptor; ATP-binding cassette transporter; Pharmacogenetics; Medicine; Biology; Internal medicine; Biochemistry; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.0861631247075621,"gpt":0.4553976741284672,"spread":0.3692345494209051,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.02901292,0.000225279,0.002226726,0.0002438523,0.00007632538,0.000006740899,0.0002983452,0.0002072021,0.00004273281],"category_scores_gemma":[0.0005506654,0.0001155679,0.0005192828,0.0002536945,0.0006018435,0.00005510201,0.00003684813,0.0008554319,5.112086e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003865263,"about_ca_system_score_gemma":0.0002750902,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004500628,"about_ca_topic_score_gemma":0.000006917827,"domain_scores_codex":[0.9946471,0.002059763,0.002674312,0.0002204416,0.0001803215,0.0002181055],"domain_scores_gemma":[0.9881728,0.009989582,0.001255688,0.0002180042,0.0001843754,0.0001796011],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.04621375,0.0004709133,0.0002780109,0.004319305,0.001032482,0.000005145656,0.005606028,0.000004140425,0.0002931039,0.001131355,0.002127864,0.9385179],"study_design_scores_gemma":[0.008440458,0.0004080266,0.009912665,0.003008586,0.007445758,0.0001103814,0.0005848029,0.000008915169,0.00004733547,0.001091347,0.9687467,0.0001949797],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1104726,0.86745,0.00107867,0.01512319,0.002031945,0.003694177,0.00007069125,0.00001400943,0.00006470343],"genre_scores_gemma":[0.06709053,0.9304568,0.001143129,0.0006302794,0.0005176325,0.00002096142,0.000006193407,0.00003671378,0.00009781157],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9666189,"threshold_uncertainty_score":0.9998356,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2108043165","doi":"10.1177/0091270007310385","title":"Sex, Race, and Smoking Impact Olanzapine Exposure","year":2008,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"National Institute of Mental Health; National Institutes of Health","keywords":"Olanzapine; Antipsychotic; Clearance; Medicine; Population; Pharmacokinetics; Volume of distribution; Internal medicine; Atypical antipsychotic; Schizophrenia (object-oriented programming); Psychiatry; Urology; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.1035252864234528,"gpt":0.4766105004904442,"spread":0.3730852140669915,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001969822,0.0001027983,0.0005974983,0.0000756327,0.00009949244,0.000003690262,0.0001173596,0.00008360591,0.0005169067],"category_scores_gemma":[0.0003916553,0.00004947503,0.0002102764,0.00009040657,0.0003019669,0.00005548724,0.00005329836,0.0008617752,0.00001188202],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003225529,"about_ca_system_score_gemma":0.0003910445,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007536697,"about_ca_topic_score_gemma":0.00000144418,"domain_scores_codex":[0.9982417,0.0005098322,0.0006675336,0.00008453661,0.0002723185,0.0002240832],"domain_scores_gemma":[0.9974706,0.001585098,0.0002949682,0.0001081913,0.0001434772,0.0003977074],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0821268,0.001386493,0.7720609,0.00002728431,0.003380656,0.00443473,0.0003909748,0.00003747497,0.00474994,0.00001478848,0.08211478,0.04927512],"study_design_scores_gemma":[0.02516609,0.00726774,0.9496838,0.00002789877,0.0006947449,0.01168593,0.00003420065,0.0001348638,0.001740532,0.0002933303,0.003196768,0.00007404356],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9883599,0.003339017,0.00002371125,0.007467755,0.0004183339,0.0001493215,0.000002035208,0.000007206275,0.0002326942],"genre_scores_gemma":[0.9872795,0.009239029,0.0002765841,0.00126628,0.001640755,0.000001176476,7.75921e-7,0.00001021024,0.0002856288],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1776229,"threshold_uncertainty_score":0.5659766,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2099178340","doi":"10.1177/0091270002239824","title":"The Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Varying Degrees of Renal Function","year":2003,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Bone health and treatments","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Pharmacokinetics; Pharmacodynamics; Zoledronic acid; Medicine; Cancer; Renal function; Pharmacology; Impaired renal function; Oncology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.04579083384940286,"gpt":0.4179785158896018,"spread":0.372187682040199,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001558953,0.0001142882,0.0004969039,0.00007003723,0.00006016852,0.000001787204,0.0000985538,0.00006804086,0.00006631952],"category_scores_gemma":[0.0001209685,0.00005551983,0.00007910554,0.0001642808,0.0003132226,0.00005406879,0.00002163741,0.0006233231,5.132429e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004228781,"about_ca_system_score_gemma":0.0003673257,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000253097,"about_ca_topic_score_gemma":0.00002418821,"domain_scores_codex":[0.9977232,0.0005417786,0.001176856,0.00008642631,0.0002540187,0.0002177432],"domain_scores_gemma":[0.9974642,0.0009726195,0.001034232,0.00008078969,0.0002988038,0.0001493779],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03820338,0.002574428,0.9075193,0.0001846082,0.001653658,0.00003107897,0.0002300269,0.002348498,0.00894902,0.00003263968,0.00103112,0.03724226],"study_design_scores_gemma":[0.07268022,0.01008367,0.8890892,0.0003115317,0.00533324,0.0001456963,0.00006988012,0.004162424,0.01316802,0.0001753741,0.004596827,0.0001839718],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945337,0.003374249,0.00006422304,0.0007333603,0.0008417609,0.0003136673,0.000005220946,0.000002187936,0.0001316737],"genre_scores_gemma":[0.9900093,0.009163886,0.0001348857,0.0005496975,0.00009885457,0.000004119779,8.313299e-7,0.00001205518,0.00002635489],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03705829,"threshold_uncertainty_score":0.2708063,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2039223287","doi":"10.1177/00912700122012751","title":"Pharmacokinetics of Gemtuzumab Ozogamicin, an Antibody‐Targeted Chemotherapy Agent for the Treatment of Patients with Acute Myeloid Leukemia in First Relapse","year":2001,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Gemtuzumab ozogamicin; Calicheamicin; Pharmacokinetics; CD33; Medicine; Pharmacology; Myeloid leukemia; Radioimmunotherapy; Chemotherapy; Antibody; Internal medicine; Monoclonal antibody; Immunology; Stem cell; CD34","retraction":null,"screen_n_in":null,"score":{"opus":0.05835483957096098,"gpt":0.439846833137735,"spread":0.381491993566774,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001134744,0.0001938168,0.0008828642,0.0001205709,0.00007397291,0.000003115352,0.0003624767,0.0001049316,0.0003177625],"category_scores_gemma":[0.00006056163,0.00008640705,0.0003093696,0.0002299265,0.0005053317,0.00005790666,0.00002989677,0.0004373989,0.000001941729],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001408529,"about_ca_system_score_gemma":0.0003953433,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008164041,"about_ca_topic_score_gemma":0.00002450844,"domain_scores_codex":[0.9973991,0.0003202307,0.001385219,0.0001478854,0.0004291041,0.0003184465],"domain_scores_gemma":[0.9961575,0.002119146,0.0008426863,0.0002045989,0.0005145072,0.000161541],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3590023,0.01315377,0.4760233,0.0002478098,0.007621204,0.0003705044,0.002507439,0.003296748,0.05002628,0.0000222405,0.01110134,0.07662714],"study_design_scores_gemma":[0.05552317,0.03968332,0.7638049,0.0001100869,0.002360972,0.000158648,0.000138434,0.005319877,0.0200431,0.00007593126,0.1125864,0.0001950782],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929996,0.0008609563,0.000116,0.004501041,0.0005173429,0.0009042794,0.00004179218,0.000003650652,0.00005540146],"genre_scores_gemma":[0.9488037,0.04862173,0.0003340623,0.001231031,0.0006432848,0.000007650415,0.00001842285,0.00002451732,0.000315591],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3034791,"threshold_uncertainty_score":0.3523577,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1978332054","doi":"10.1177/0091270010373928","title":"Patterns of Antidepressant Medication Use Among Pregnant Women in a United States Population","year":2010,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; Child and Family Research Institute","funders":"","keywords":"Antidepressant; Bupropion; Pregnancy; Medicine; Population; Telephone interview; Obstetrics; Pediatrics; Psychiatry; Environmental health; Smoking cessation","retraction":null,"screen_n_in":null,"score":{"opus":0.05618413982299384,"gpt":0.4272779569408325,"spread":0.3710938171178386,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003182605,0.00007954692,0.0004399842,0.0001549696,0.00002505081,0.000002983369,0.0001510079,0.0001073664,0.0001918787],"category_scores_gemma":[0.0003871928,0.00004741974,0.00006771515,0.00009575539,0.0001012523,0.000115191,0.00003768862,0.0008715013,0.000001800787],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002612844,"about_ca_system_score_gemma":0.0000672415,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000396699,"about_ca_topic_score_gemma":0.00004947379,"domain_scores_codex":[0.9975282,0.0005509936,0.00140392,0.00007581243,0.0002234386,0.0002176642],"domain_scores_gemma":[0.997281,0.001239947,0.001018689,0.0001262226,0.0001227851,0.0002113545],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00281251,0.00045709,0.9935797,0.000398093,0.00006376581,0.00004476029,0.00062943,0.0000893536,0.001013463,0.000008696507,0.00007469207,0.0008283757],"study_design_scores_gemma":[0.002774814,0.0007314013,0.9913039,0.001282257,0.00009571866,0.00008282906,0.00006003462,0.0007053561,0.002424483,0.0001658274,0.0003325918,0.00004079558],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967169,0.00007089734,0.00002365136,0.001260114,0.001648764,0.0002584572,0.000007336252,0.000005142495,0.000008731662],"genre_scores_gemma":[0.9966013,0.002043765,0.00004893366,0.0009090398,0.0003028746,0.000004617722,0.000009093264,0.000008870727,0.00007150164],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002795412,"threshold_uncertainty_score":0.3786288,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1900044360","doi":"10.1002/jcph.616","title":"Folic acid supplementation for pregnant women and those planning pregnancy: 2015 update","year":2015,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; Canadian College of Naturopathic Medicine; Hospital for Sick Children; SickKids Foundation; University of Toronto; Western University; Mount Sinai Hospital","funders":"","keywords":"Folic acid; Medicine; Fortification; Pregnancy; Folic acid supplementation; Food fortification; Family planning; Population; Environmental health; Food science; Internal medicine; Chemistry; Research methodology; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.3434866197943854,"gpt":0.610873603915441,"spread":0.2673869841210556,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00666351,0.0002647479,0.002390887,0.0002077891,0.00007791264,0.00001711448,0.0003616707,0.0003141984,0.0002030538],"category_scores_gemma":[0.0004710577,0.0001374406,0.0004073126,0.000147911,0.000222107,0.0001101213,0.0001605536,0.001339308,0.00002037267],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001270589,"about_ca_system_score_gemma":0.001390679,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001155217,"about_ca_topic_score_gemma":4.503257e-7,"domain_scores_codex":[0.9958078,0.001149994,0.001991085,0.0002038634,0.0003838878,0.0004633963],"domain_scores_gemma":[0.9957208,0.001769193,0.001426239,0.0001878134,0.0004253265,0.0004706186],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001485833,0.0002518612,0.00001981641,0.004020473,0.001407623,0.000103352,0.0003549971,7.362057e-7,0.00001517176,0.000003350898,0.1307194,0.8616174],"study_design_scores_gemma":[0.005379862,0.004223213,0.00001374231,0.008278142,0.003483925,0.0005288626,0.00007718162,0.00002970869,0.00001123598,0.0001848169,0.9776599,0.0001293702],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007520462,0.9952844,0.00006311739,0.001015529,0.001150832,0.001592703,0.00005043305,0.000007566425,0.00008330579],"genre_scores_gemma":[0.0001361256,0.9962895,0.0002678063,0.0004976538,0.001923688,0.00007768538,0.00003813511,0.00004449706,0.0007249168],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.861488,"threshold_uncertainty_score":0.5818703,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2000782600","doi":"10.1177/0091270004269521","title":"Pharmacokinetics of Dextromethorphan After Single or Multiple Dosing in Combination With Quinidine in Extensive and Poor Metabolizers","year":2004,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Respiratory and Cough-Related Research","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Dextromethorphan; Dextrorphan; Dosing; Pharmacokinetics; Quinidine; Pharmacology; CYP2D6; Medicine; Urine; Oral administration; Debrisoquine; Bioequivalence; Internal medicine; Metabolism; Cytochrome P450","retraction":null,"screen_n_in":null,"score":{"opus":0.09137928177373802,"gpt":0.4431224183699279,"spread":0.3517431365961899,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003114749,0.0001128969,0.000653193,0.0002813464,0.00002227615,0.000004440139,0.0001192865,0.0001161635,0.0000958597],"category_scores_gemma":[0.0007667248,0.00006140801,0.00007406227,0.0004175495,0.0004103479,0.0001081827,0.0000442238,0.001019348,0.000001265026],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004640406,"about_ca_system_score_gemma":0.000267112,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001526544,"about_ca_topic_score_gemma":0.00002194235,"domain_scores_codex":[0.9974287,0.0008359905,0.001109834,0.0001188414,0.0002887677,0.0002179136],"domain_scores_gemma":[0.9972944,0.001694883,0.0004493419,0.0000788126,0.0003358993,0.0001467177],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.1773302,0.005622139,0.09741598,0.0002157343,0.0007657182,0.003020884,0.001540137,0.003523322,0.6767203,0.0000224412,0.0002660606,0.03355706],"study_design_scores_gemma":[0.161474,0.02408688,0.5435681,0.001055943,0.001940851,0.001691101,0.001458254,0.001762643,0.2590655,0.0007486519,0.002791826,0.0003562128],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941307,0.001703051,0.0001963267,0.00331791,0.0002854237,0.0003213218,0.000001221427,0.000002889075,0.0000411367],"genre_scores_gemma":[0.9957151,0.00165157,0.0008435277,0.001571678,0.000177746,0.000003854596,3.367841e-7,0.00001391308,0.00002232044],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4461522,"threshold_uncertainty_score":0.4428615,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2008423993","doi":"10.1177/0091270003261078","title":"Effects of St. John's Wort (<i>Hypericum perforatum</i>) on Tacrolimus Pharmacokinetics in Healthy Volunteers","year":2003,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":113,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Center for Research Resources","keywords":"Pharmacokinetics; Hypericum perforatum; Tacrolimus; Pharmacology; CYP3A; Volume of distribution; Medicine; Pharmacokinetic interaction; Oral administration; Dosing; Drug interaction; Chemistry; Transplantation; Metabolism; Internal medicine; Cytochrome P450","retraction":null,"screen_n_in":null,"score":{"opus":0.09962250996604795,"gpt":0.4859302468162513,"spread":0.3863077368502034,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.01056599,0.0005094061,0.001618436,0.000439139,0.0001909416,0.00001116156,0.001141788,0.0005668745,0.001267098],"category_scores_gemma":[0.001187901,0.000369657,0.0005689119,0.0007719733,0.0008575569,0.0001312393,0.0001336335,0.004480775,0.00006560674],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009048108,"about_ca_system_score_gemma":0.0006832225,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009477145,"about_ca_topic_score_gemma":0.000004659571,"domain_scores_codex":[0.9872298,0.007596173,0.003208016,0.0003889688,0.0005833754,0.0009937291],"domain_scores_gemma":[0.9887505,0.007982261,0.0017545,0.0002843744,0.0004872588,0.0007411151],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.07968273,0.02126916,0.04709026,0.0009936339,0.00453655,0.00198053,0.002903951,0.05265424,0.493739,0.001833678,0.228347,0.06496928],"study_design_scores_gemma":[0.03799365,0.00494389,0.01368843,0.00008119456,0.002659868,0.0003081566,0.0002007534,0.00290845,0.2308082,0.0008885057,0.7048169,0.000701944],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9679263,0.007708369,0.00008217316,0.00233185,0.01842721,0.0008276531,0.00002934679,0.00002065156,0.002646497],"genre_scores_gemma":[0.9563897,0.02211204,0.0001969944,0.01923425,0.001785718,0.00002081847,0.000001995393,0.00006245154,0.0001959768],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.47647,"threshold_uncertainty_score":0.9998755,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2046257359","doi":"10.1177/0091270005280297","title":"Aging and Clinical Pharmacology: Implications for Antidepressants","year":2005,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Baycrest Hospital","funders":"National Institute of Mental Health","keywords":"Antidepressant; Medicine; Clinical trial; Depression (economics); Polypharmacy; Adverse effect; Clinical pharmacology; Pharmacokinetics; Intensive care medicine; Psychiatry; Pharmacology; Internal medicine; Anxiety","retraction":null,"screen_n_in":null,"score":{"opus":0.3226000273440726,"gpt":0.6227360357906193,"spread":0.3001360084465468,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006649537,0.0004726286,0.00441846,0.0002379707,0.0001830991,0.00001470799,0.0006553115,0.0007576444,0.0002187275],"category_scores_gemma":[0.0009689684,0.0002623564,0.001815444,0.000171085,0.0006897639,0.0001170256,0.0002690618,0.002618398,0.00002963232],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000807439,"about_ca_system_score_gemma":0.000899423,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001001267,"about_ca_topic_score_gemma":6.77024e-7,"domain_scores_codex":[0.9919749,0.002270247,0.004611535,0.0004406525,0.000233492,0.0004690992],"domain_scores_gemma":[0.9783322,0.01648383,0.003857723,0.0003748701,0.0003762101,0.000575149],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007786148,0.001065119,0.00144016,0.001102027,0.003125875,0.00004238275,0.000007432644,0.000001037385,0.00001325449,0.000005354674,0.1357132,0.8567055],"study_design_scores_gemma":[0.008387942,0.001361813,0.004831033,0.00175621,0.03667245,0.001868435,0.00000342594,0.00002078056,0.000005381061,0.00006059299,0.9448354,0.0001965492],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001500901,0.9813192,0.0001466718,0.008715335,0.00597939,0.002106942,0.00005645492,0.00003324743,0.0001417784],"genre_scores_gemma":[0.0005236815,0.9790644,0.001235973,0.003362386,0.01532011,0.00004760794,0.00001711295,0.00008462663,0.0003440914],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.856509,"threshold_uncertainty_score":0.9999829,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2103407911","doi":"10.1002/jcph.564","title":"Food effects on abiraterone pharmacokinetics in healthy subjects and patients with metastatic castration‐resistant prostate cancer","year":2015,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"Astellas Pharma; Pfizer","keywords":"Abiraterone acetate; Pharmacokinetics; Prostate cancer; Medicine; Meal; Prednisone; Endocrinology; Internal medicine; Adverse effect; Cancer; Androgen deprivation therapy","retraction":null,"screen_n_in":null,"score":{"opus":0.09995530838740403,"gpt":0.4608467841323652,"spread":0.3608914757449612,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001533445,0.0001410318,0.0005292784,0.0001171206,0.0000407808,0.000008770236,0.00009070396,0.00004243516,0.0000213848],"category_scores_gemma":[0.0001322956,0.0000698016,0.00004250585,0.0001762205,0.0002006155,0.00007373383,0.00002754972,0.00065758,0.000002990281],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001206067,"about_ca_system_score_gemma":0.0006730133,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001842965,"about_ca_topic_score_gemma":0.00003277067,"domain_scores_codex":[0.9977567,0.0007383691,0.0006899574,0.000133163,0.0003998792,0.0002819209],"domain_scores_gemma":[0.9979026,0.0008883649,0.0003872589,0.00008085908,0.000358006,0.0003829211],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.527475,0.004660081,0.412515,0.0006668966,0.002037388,0.001027443,0.001957205,0.0007752044,0.004480706,0.00001111827,0.01064682,0.03374716],"study_design_scores_gemma":[0.1699913,0.1471867,0.6657205,0.0004443104,0.001746739,0.0001029061,0.0002041651,0.0002497306,0.01126332,0.0002446766,0.002596368,0.0002492096],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9887092,0.00199463,0.000003872945,0.007714659,0.0006431681,0.0008699388,0.00001098673,0.000004796094,0.0000487125],"genre_scores_gemma":[0.994802,0.002195899,0.00009468706,0.002489907,0.0003263832,0.00001961522,0.000003113328,0.00001721238,0.00005117168],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3574837,"threshold_uncertainty_score":0.2856895,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3196156655","doi":"10.1002/jcph.1937","title":"The Epidemiology of Drug Abuse","year":2021,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Substance Abuse Treatment and Outcomes","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Children's Hospital; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Epidemiology; Psychosocial; Recreational Drug; Pandemic; Psychiatry; Psychological intervention; Medicine; Addiction; Substance abuse; Drug; Recreation; Substance use; Disease; Psychology; Coronavirus disease 2019 (COVID-19); Infectious disease (medical specialty); Political science","retraction":null,"screen_n_in":null,"score":{"opus":0.3005264578466595,"gpt":0.5699602311900364,"spread":0.2694337733433768,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0102559,0.0003007291,0.005874514,0.00008812871,0.00009148304,0.000001791412,0.0006648588,0.0003385587,0.0003518045],"category_scores_gemma":[0.003058454,0.000113229,0.002573624,0.0002389289,0.000781753,0.00003157516,0.00007295889,0.002045239,0.00003922406],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005892496,"about_ca_system_score_gemma":0.0009682243,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000136397,"about_ca_topic_score_gemma":0.000004522252,"domain_scores_codex":[0.9890844,0.005663494,0.004514603,0.0001627934,0.0002304064,0.0003443363],"domain_scores_gemma":[0.9344127,0.06026286,0.004351495,0.0004162346,0.0003640034,0.0001927347],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009577533,0.0004759393,0.002747735,0.0008663816,0.00762007,0.0003794615,0.0002841146,0.000001914595,6.097897e-7,0.0001076171,0.1427289,0.8438295],"study_design_scores_gemma":[0.002348734,0.0003722981,0.0002371217,0.002445143,0.01441928,0.0008693588,0.0001221523,0.000001426261,0.000003722451,0.0001022691,0.9789922,0.00008627341],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002554785,0.9886646,0.000005515265,0.002958126,0.005241026,0.000412088,0.000001887629,0.000006242362,0.0001557249],"genre_scores_gemma":[0.0001803488,0.9938409,0.0001153836,0.002203664,0.002485184,0.000006567882,0.000003509821,0.00003218063,0.001132314],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8437432,"threshold_uncertainty_score":0.8885661,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2128897405","doi":"10.1177/0091270011415528","title":"Evaluation of Exposure Change of Nonrenally Eliminated Drugs in Patients With Chronic Kidney Disease Using Physiologically Based Pharmacokinetic Modeling and Simulation","year":2012,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Physiologically based pharmacokinetic modelling; Pharmacokinetics; Pharmacology; Telithromycin; Repaglinide; Renal function; Bioavailability; Medicine; Bioequivalence; In vivo; Chemistry; Internal medicine; Antibacterial agent; Antibiotics; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.1629824475766013,"gpt":0.4566286350482465,"spread":0.2936461874716452,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005350392,0.0001487963,0.0006845798,0.0001142971,0.00003811834,0.000001522766,0.0001020963,0.00008167577,0.0001212701],"category_scores_gemma":[0.0009738291,0.00007990796,0.0001126945,0.000182363,0.0002403708,0.0001383136,0.0000551651,0.0004155517,2.954675e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007539312,"about_ca_system_score_gemma":0.0002729554,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005104397,"about_ca_topic_score_gemma":3.165677e-7,"domain_scores_codex":[0.9964792,0.001549228,0.001023389,0.0001123518,0.0006064535,0.000229347],"domain_scores_gemma":[0.9966186,0.001152749,0.0008692692,0.00007655428,0.00100443,0.0002783631],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.03563813,0.005522075,0.2953655,0.0004705441,0.0008160705,0.00000636679,0.0005095357,0.6020742,0.04174305,0.000001365069,0.00005355274,0.01779958],"study_design_scores_gemma":[0.01352152,0.002105301,0.4606667,0.0001573556,0.002505446,6.918789e-7,0.00001070116,0.5204219,0.0005289664,0.00001618083,0.000005202916,0.00006001097],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969459,0.001259905,0.0002335409,0.0004465227,0.0002852074,0.000808027,0.000007808015,0.000003950641,0.000009114439],"genre_scores_gemma":[0.99806,0.0002197286,0.0001215389,0.001101942,0.000475662,0.000006788865,0.000003665976,0.00001016872,5.4398e-7],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1653011,"threshold_uncertainty_score":0.3258552,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1974773091","doi":"10.1177/00912700222011607","title":"Clinical Pharmacokinetics of Verteporfin","year":2002,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"QLT (Canada)","funders":"","keywords":"Verteporfin; Pharmacokinetics; Cmax; Macular degeneration; Choroidal neovascularization; Medicine; Metabolite; Ophthalmology; Pharmacology; Urology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1711532709707249,"gpt":0.5130131808709297,"spread":0.3418599099002048,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002029569,0.0001268529,0.0008920805,0.00005808058,0.00003271593,0.000002372785,0.0002569594,0.0001193547,0.002763433],"category_scores_gemma":[0.0005900255,0.00007015107,0.0006942907,0.0001301711,0.0004542526,0.00004204871,0.00005758421,0.0007491009,0.00008059976],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001406364,"about_ca_system_score_gemma":0.00009446279,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002358843,"about_ca_topic_score_gemma":1.507182e-7,"domain_scores_codex":[0.9962466,0.0007783651,0.002329891,0.0001106552,0.0003351565,0.0001993774],"domain_scores_gemma":[0.9958485,0.002007182,0.00124596,0.0001805144,0.0003428674,0.0003749374],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.01348938,0.01073313,0.4126675,0.0001152008,0.003931158,0.001372758,0.0001084691,0.00005460539,0.002886226,0.00003705046,0.4148105,0.139794],"study_design_scores_gemma":[0.04188352,0.01580616,0.759419,0.0001758976,0.01342712,0.001699942,0.00007949627,0.003862896,0.002532908,0.0004878828,0.1603782,0.0002470071],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9861068,0.002759655,0.00004973587,0.00533387,0.002658962,0.000202354,0.000005628953,0.000006937238,0.002876104],"genre_scores_gemma":[0.9789426,0.01426831,0.0002910303,0.004025233,0.001902253,8.543556e-7,7.574391e-7,0.00001499289,0.0005539207],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3467514,"threshold_uncertainty_score":0.9981482,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2138758167","doi":"10.1177/00912700222011210","title":"Multiple‐Dose, Linear, Dose‐Proportional Pharmacokinetics of Retigabine in Healthy Volunteers","year":2002,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Pharmacokinetics; Medicine; Evening; Placebo; Population; Morning; Volume of distribution; Pharmacology; Oral administration; Anesthesia; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1399570670173916,"gpt":0.478575900618726,"spread":0.3386188336013344,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003153665,0.0001529668,0.0008302507,0.0001976107,0.0000414863,0.000002119594,0.0002617103,0.0001324529,0.002291782],"category_scores_gemma":[0.001082488,0.00009190454,0.000307435,0.0002920569,0.0005183389,0.00005680657,0.00006622296,0.00142047,0.00005020225],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007634987,"about_ca_system_score_gemma":0.0002760565,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002513107,"about_ca_topic_score_gemma":0.00000936624,"domain_scores_codex":[0.9959958,0.0007651015,0.002127435,0.000148653,0.0005830555,0.0003799986],"domain_scores_gemma":[0.9960716,0.002094579,0.0007539241,0.000168983,0.0004683502,0.0004425797],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06157863,0.01415019,0.7492907,0.0002763577,0.0018187,0.001258763,0.0005346349,0.00123802,0.02109512,0.0000274718,0.1220655,0.02666589],"study_design_scores_gemma":[0.1096132,0.0322841,0.7548966,0.0002586474,0.001557737,0.001308692,0.0002239035,0.04269621,0.009087715,0.0002188829,0.04753069,0.0003236678],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9706127,0.001676847,0.00003270685,0.02564853,0.001004491,0.0004395755,0.000008890704,0.000007424258,0.0005688207],"genre_scores_gemma":[0.9838027,0.01077955,0.0007158843,0.002980502,0.001318943,0.000004931646,0.000003589821,0.00001826908,0.0003756431],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07453481,"threshold_uncertainty_score":0.9986203,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2076382338","doi":"10.1177/0091270011413588","title":"Current Understanding of Drug Disposition in Kidney Disease","year":2012,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Kidney disease; Drug; Pharmacology; Disposition; Drug metabolism; Renal function; Population; Kidney; Pharmacokinetics; Parathyroid hormone; Disease; Internal medicine; Calcium","retraction":null,"screen_n_in":null,"score":{"opus":0.3383451380319334,"gpt":0.5491011623739794,"spread":0.210756024342046,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005123285,0.0002882744,0.003158869,0.000221869,0.00005477246,0.000003343993,0.0003152353,0.0001607417,0.0002724015],"category_scores_gemma":[0.0008757587,0.0001419476,0.001110001,0.0002750429,0.0004725429,0.000073681,0.0001643917,0.002241006,0.00001240726],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002214901,"about_ca_system_score_gemma":0.000639399,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001505388,"about_ca_topic_score_gemma":4.77304e-7,"domain_scores_codex":[0.9942209,0.002408605,0.002556042,0.0001482931,0.0003367052,0.0003294319],"domain_scores_gemma":[0.9919047,0.004983862,0.002196833,0.0001326896,0.0001077357,0.0006742154],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.006864736,0.007128413,0.001970758,0.04682105,0.003514317,0.0004255944,0.0002427905,0.000009909871,0.00003288049,0.0002503956,0.05752901,0.8752102],"study_design_scores_gemma":[0.004400341,0.0006881217,0.001345174,0.0140725,0.02478408,0.0001027877,0.00002659317,0.00002862964,0.000005040804,0.0004166299,0.9539184,0.0002117074],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001159023,0.9917461,0.00006872357,0.001620802,0.004475934,0.0007755189,0.00002833421,0.000006202581,0.0001193769],"genre_scores_gemma":[0.03392676,0.9625128,0.00001074006,0.0009034017,0.002588531,0.000008920779,0.000006818179,0.00002061802,0.00002141454],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8963894,"threshold_uncertainty_score":0.973618,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1995726799","doi":"10.1177/0091270010378858","title":"Incidence and Contributors to Potential Drug‐Drug Interactions in Hospitalized Patients","year":2010,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Drug; Incidence (geometry); Medicine; Intensive care medicine; Pharmacology","retraction":null,"screen_n_in":null,"score":{"opus":0.07025344659038651,"gpt":0.5034002863795165,"spread":0.43314683978913,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002599123,0.0001090075,0.0005057147,0.0001115841,0.00005843226,0.00001048229,0.0001914553,0.00004188682,0.0004609058],"category_scores_gemma":[0.002362446,0.00006614428,0.000135222,0.0001346651,0.0001770117,0.0002120934,0.0001168587,0.001775179,0.00002727584],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002124223,"about_ca_system_score_gemma":0.00009939527,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003606643,"about_ca_topic_score_gemma":0.00003778117,"domain_scores_codex":[0.9977641,0.0005417574,0.001118818,0.0001145568,0.0002459919,0.0002147755],"domain_scores_gemma":[0.9958373,0.00282323,0.0005516242,0.0001012755,0.0002843387,0.0004022423],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008199579,0.001142573,0.9605343,0.00001718731,0.0001740801,0.00009081767,0.0003729369,0.00002197855,0.004858476,0.00001581038,0.01873609,0.005836224],"study_design_scores_gemma":[0.01156462,0.0006173374,0.9354018,0.00003935507,0.0006062798,0.0001444514,0.00007419771,0.0006679471,0.0008096156,0.0002120249,0.04975122,0.0001111389],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9682309,0.00006046384,0.0000320224,0.02467687,0.006426334,0.0003802774,0.000003891696,0.000005846047,0.0001833849],"genre_scores_gemma":[0.9884806,0.0002649593,0.0002059298,0.0101222,0.0007687121,0.000002680304,9.59358e-7,0.000008957934,0.0001450123],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03101514,"threshold_uncertainty_score":0.7712368,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2150276412","doi":"10.1177/0091270004265642","title":"The Influence of St. John's Wort on CYP2C19 Activity with Respect to Genotype","year":2004,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":79,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Genotype; CYP2C19; Medicine; Traditional medicine; Pharmacology; Genetics; Biology; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.1481938087109592,"gpt":0.5163174603508064,"spread":0.3681236516398472,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008633412,0.0003108158,0.0008172003,0.0001469406,0.0004177569,0.00001548282,0.001421083,0.0002712266,0.0002674199],"category_scores_gemma":[0.00067676,0.0001615932,0.0002884436,0.0004913696,0.001005611,0.0001077704,0.0002081066,0.002802609,0.00007941072],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007219204,"about_ca_system_score_gemma":0.0007349928,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001703245,"about_ca_topic_score_gemma":0.00002695323,"domain_scores_codex":[0.9945577,0.002552538,0.001481712,0.0002597573,0.0005319157,0.0006163343],"domain_scores_gemma":[0.9914161,0.00563294,0.001392895,0.000359524,0.0006321332,0.0005664172],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","study_design_scores_codex":[0.09248932,0.003730586,0.006727504,0.00004727743,0.003268488,0.0004040094,0.0013619,0.4572594,0.3373525,0.001509299,0.03108767,0.06476203],"study_design_scores_gemma":[0.01708044,0.008087569,0.1380798,0.0000700835,0.002292939,0.0003117787,0.0001135621,0.0001685004,0.2414268,0.003430695,0.5883823,0.0005555328],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9779232,0.000729327,0.0001263653,0.01585172,0.003537837,0.0005399344,0.00002755678,0.0000165099,0.00124751],"genre_scores_gemma":[0.9806641,0.004033407,0.0001609464,0.01331154,0.001623205,0.00001121605,4.197676e-7,0.00003312054,0.00016207],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5572947,"threshold_uncertainty_score":0.999498,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2972367557","doi":"10.1002/jcph.1493","title":"Characterization of the Ontogeny of Hepatic UDP‐Glucuronosyltransferase Enzymes Based on Glucuronidation Activity Measured in Human Liver Microsomes","year":2019,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":77,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"F. Hoffmann-La Roche","keywords":"UGT2B7; Glucuronidation; Microsome; Gene isoform; Glucuronosyltransferase; Isozyme; In vivo; Enzyme; Internal medicine; Endocrinology; Pharmacokinetics; Ontogeny; In vitro; Chemistry; Pharmacology; Biology; Biochemistry; Medicine; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.1274788103650919,"gpt":0.4600267149257834,"spread":0.3325479045606915,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005776862,0.0002492488,0.0008908158,0.0001969015,0.0001138505,0.00000545421,0.0008281822,0.000310125,0.001113155],"category_scores_gemma":[0.0002984555,0.0001603491,0.0004257056,0.0003321511,0.0004940753,0.000130105,0.00007969934,0.001458497,0.00001293792],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005044081,"about_ca_system_score_gemma":0.0003646668,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000209162,"about_ca_topic_score_gemma":0.00001403293,"domain_scores_codex":[0.9920684,0.005202722,0.001801278,0.0002068823,0.0003950831,0.00032564],"domain_scores_gemma":[0.9950046,0.002298324,0.001828246,0.0002827449,0.0004396506,0.0001464227],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.004034677,0.001698167,0.04172171,0.00008709119,0.0002356508,0.000005299847,0.0003311424,0.003842589,0.9424114,0.00006132502,0.000228794,0.005342152],"study_design_scores_gemma":[0.006518513,0.0005902722,0.1761091,0.00004405475,0.0005884338,0.000005808798,0.00001313808,0.005595181,0.8061316,0.00007660505,0.004192692,0.0001345798],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922711,0.0003815583,0.0001120692,0.001308788,0.004878639,0.0007439518,0.000058559,0.00000645149,0.0002389268],"genre_scores_gemma":[0.9957872,0.001094355,0.00001999244,0.002482821,0.0005019391,0.000006719943,0.00000471618,0.00002445925,0.00007779988],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1362798,"threshold_uncertainty_score":0.9998,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2056389297","doi":"10.1177/0091270008319794","title":"Same Drug, Different Dosing: Differences in Dosing for Drugs Approved in the United States, Europe, and Japan","year":2008,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Nutrasource","funders":"","keywords":"Dosing; Medicine; Drug; Pharmacology","retraction":null,"screen_n_in":null,"score":{"opus":0.207105375854416,"gpt":0.4668571482132321,"spread":0.2597517723588161,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003818815,0.0001553949,0.0007025356,0.0001070298,0.0001541329,0.00001294126,0.0002740042,0.00006421284,0.00003501561],"category_scores_gemma":[0.0008926364,0.00007017406,0.0001038916,0.0002940757,0.0005117822,0.00007849813,0.0000874068,0.001275292,0.000001254033],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000227865,"about_ca_system_score_gemma":0.00006562198,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000844645,"about_ca_topic_score_gemma":0.00002277792,"domain_scores_codex":[0.9965774,0.001619677,0.00111709,0.0001377721,0.0002392867,0.0003087272],"domain_scores_gemma":[0.9864813,0.01261477,0.000530711,0.00009080939,0.0001369105,0.000145467],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.07164665,0.008863864,0.7314096,0.0004509325,0.001947157,0.0006279082,0.04156795,0.0001355076,0.00858456,0.0002754468,0.0782185,0.05627189],"study_design_scores_gemma":[0.02637581,0.002823139,0.7503771,0.0001881138,0.00133703,0.0006175835,0.004682064,0.008825041,0.0005040649,0.0008321921,0.2031542,0.0002836655],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9437962,0.001815807,0.00004017817,0.05320051,0.0005382354,0.0004190199,0.000002931568,0.000004753953,0.000182429],"genre_scores_gemma":[0.9560344,0.02641263,0.00005762919,0.01683113,0.0005807625,0.000006626926,0.000002087283,0.00001074315,0.00006394307],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1249357,"threshold_uncertainty_score":0.5540581,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2153132143","doi":"10.1002/jcph.526","title":"Evaluation of the effect of food and gastric pH on the single‐dose pharmacokinetics of cabozantinib in healthy adult subjects","year":2015,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Celerion (Canada)","funders":"Exelixis","keywords":"Cabozantinib; Pharmacokinetics; Esomeprazole; Bioavailability; Tyrosine-kinase inhibitor; Medicine; Pharmacology; Medullary thyroid cancer; Gastroenterology; Concomitant; Drug interaction; Internal medicine; Drug; Cancer; Thyroid cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.1295850874211154,"gpt":0.4499434924723286,"spread":0.3203584050512132,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01325412,0.0001462885,0.0007922614,0.0001078234,0.00002381279,0.000001432897,0.0002745253,0.0001047903,0.00004954827],"category_scores_gemma":[0.004828752,0.00006399392,0.0001824802,0.0003202069,0.0004333563,0.00003064127,0.00007916867,0.0007574206,0.000001217587],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001873052,"about_ca_system_score_gemma":0.001054374,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002214836,"about_ca_topic_score_gemma":0.00001157122,"domain_scores_codex":[0.9926406,0.004597454,0.001522884,0.0001129526,0.0009303235,0.0001957864],"domain_scores_gemma":[0.9911876,0.00586169,0.001787333,0.0002330019,0.000796198,0.0001342281],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.2050922,0.01068479,0.2760863,0.001200128,0.00611242,0.00007508352,0.004697,0.007036682,0.2835727,0.0001006461,0.02198963,0.1833524],"study_design_scores_gemma":[0.1995417,0.09735869,0.1992869,0.0009034323,0.01236779,0.000586804,0.0003807175,0.007385173,0.4810426,0.0005574769,0.000390398,0.0001983024],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927823,0.001305646,0.000002906667,0.003699519,0.0009562403,0.0009373694,0.000006363934,0.000002062262,0.0003075836],"genre_scores_gemma":[0.9981553,0.0006596905,0.00002180136,0.0008031139,0.0003342797,0.000005136259,5.205317e-7,0.0000133212,0.000006864474],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1974699,"threshold_uncertainty_score":0.5780817,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2086291342","doi":"10.1002/jcph.510","title":"Pharmacokinetic (PK) drug interaction studies of cabozantinib: Effect of CYP3A inducer rifampin and inhibitor ketoconazole on cabozantinib plasma PK and effect of cabozantinib on CYP2C8 probe substrate rosiglitazone plasma PK","year":2015,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Celerion (Canada)","funders":"Exelixis","keywords":"Cabozantinib; Pharmacology; Ketoconazole; CYP3A4; Pharmacokinetics; CYP3A; Drug interaction; Tyrosine-kinase inhibitor; Chemistry; Medicine; Cytochrome P450; Internal medicine; Cancer; Metabolism","retraction":null,"screen_n_in":null,"score":{"opus":0.09779140068654354,"gpt":0.4436915727444264,"spread":0.3459001720578828,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007266114,0.000595213,0.00297016,0.0004087783,0.00007578015,0.00001071223,0.0002745176,0.0002700581,0.00004404892],"category_scores_gemma":[0.00156612,0.0003441815,0.0004315442,0.0003015018,0.00109535,0.0001702704,0.0001790908,0.001590615,0.000009738132],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007396884,"about_ca_system_score_gemma":0.0002567122,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005019818,"about_ca_topic_score_gemma":0.000007620357,"domain_scores_codex":[0.9920515,0.003291541,0.00293805,0.00044192,0.0008117684,0.0004651619],"domain_scores_gemma":[0.9848981,0.011101,0.002512404,0.0003161011,0.0007056701,0.0004666616],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.2202468,0.003142046,0.103707,0.002558698,0.005480512,0.0005725791,0.003044272,0.0006674181,0.6411369,0.00002007024,0.006364866,0.0130588],"study_design_scores_gemma":[0.04546393,0.03856532,0.03594044,0.001083409,0.003709241,0.0006069409,0.0003562031,0.0003617604,0.8732323,0.00001752911,0.0004257319,0.0002372107],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923281,0.00169827,0.000001640264,0.001016248,0.002453103,0.002033288,0.00003092294,0.00001800729,0.0004204096],"genre_scores_gemma":[0.9967234,0.001932974,0.00005382242,0.0001988893,0.0009172202,0.00002850986,0.000005338361,0.0000602485,0.0000796681],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2320954,"threshold_uncertainty_score":0.999901,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2094518494","doi":"10.1177/0091270003251388","title":"Pharmacokinetics of an Immediate‐Release Oral Formulation of Fampridine (4‐Aminopyridine) in Normal Subjects and Patients with Spinal Cord Injury","year":2003,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St Joseph's Health Care; Lawson Health Research Institute; Western University","funders":"","keywords":"Cmax; Pharmacokinetics; 4-Aminopyridine; Spinal cord injury; High-performance liquid chromatography; Oral administration; Medicine; Plasma concentration; Spinal cord; Anesthesia; Chemistry; Pharmacology; Chromatography; Internal medicine; Potassium channel","retraction":null,"screen_n_in":null,"score":{"opus":0.05625848757876493,"gpt":0.4250878392978557,"spread":0.3688293517190907,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000903477,0.0001360742,0.0006053123,0.0001459456,0.00002185945,0.000002223389,0.00009508786,0.00006200322,0.00006703137],"category_scores_gemma":[0.000333015,0.00008279219,0.00008717221,0.0001813329,0.0002036477,0.0001544471,0.00002429399,0.0003861841,4.173382e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001203977,"about_ca_system_score_gemma":0.0001922545,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005227179,"about_ca_topic_score_gemma":0.000003327795,"domain_scores_codex":[0.9977588,0.0005565751,0.001150221,0.0001116975,0.0002606768,0.0001620361],"domain_scores_gemma":[0.9980022,0.0003972449,0.0008167755,0.00009840664,0.0004712791,0.000214127],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1497496,0.004398871,0.7403671,0.0001609496,0.0002354445,0.00009519488,0.0001125098,0.0002520402,0.09237287,0.00001793748,0.0004984813,0.01173898],"study_design_scores_gemma":[0.02090279,0.02015007,0.8000813,0.00007187031,0.0008370404,0.0000617483,0.00003786227,0.0005060916,0.1570194,0.0000269862,0.0002009543,0.0001038906],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9989091,0.0002051724,0.0000301548,0.0001811963,0.0003607133,0.0002742987,0.00001582107,0.000002303969,0.00002122162],"genre_scores_gemma":[0.9982394,0.0005023493,0.0001690508,0.0008144448,0.0002469107,0.000001286845,0.000007119766,0.00001324581,0.000006207638],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1288468,"threshold_uncertainty_score":0.3376168,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1627148868","doi":"10.1177/0091270011433327","title":"An Algorithm to Detect Adverse Drug Reactions in the Neonatal Intensive Care Unit","year":2012,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","keywords":"Neonatal intensive care unit; Intensive care unit; Drug reaction; Drug; Algorithm; Medicine; Adverse drug reaction; Intensive care medicine; Computer science; Pharmacology; Pediatrics","retraction":null,"screen_n_in":null,"score":{"opus":0.1715023474230395,"gpt":0.537568988025676,"spread":0.3660666406026365,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004572718,0.0001151049,0.0004094069,0.0000672768,0.0001337785,0.000004981755,0.0003290029,0.00007018651,0.0003194791],"category_scores_gemma":[0.001417273,0.00005614194,0.0001677023,0.0002317138,0.0001937312,0.0002233287,0.00007788393,0.001710411,0.00006037977],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000386668,"about_ca_system_score_gemma":0.00009250853,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005176801,"about_ca_topic_score_gemma":0.00002228204,"domain_scores_codex":[0.9969078,0.001616597,0.0008111283,0.00008525747,0.0002597925,0.0003194018],"domain_scores_gemma":[0.9938607,0.004684791,0.0003708558,0.0001485434,0.0005688139,0.000366356],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.02184979,0.001341584,0.04948349,0.00008957578,0.001805031,0.0009980623,0.05555419,0.0003108486,0.004708418,0.00004927818,0.09710254,0.7667072],"study_design_scores_gemma":[0.004215619,0.001646388,0.0880155,0.00003395261,0.001431987,0.001252714,0.05093958,0.0001954091,0.0008885394,0.0000674902,0.8511936,0.0001192299],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9543035,0.002719615,0.0002342158,0.03865816,0.002985362,0.0003774034,0.000006861615,0.000008433625,0.0007064325],"genre_scores_gemma":[0.9543521,0.001711649,0.0004562512,0.0403291,0.003092787,0.000004942213,0.000001012112,0.000009905676,0.00004219283],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.766588,"threshold_uncertainty_score":0.743098,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2008486886","doi":"10.1177/0091270009337946","title":"Effect of Age, Weight, and CYP2C19 Genotype on Escitalopram Exposure","year":2009,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of Mental Health","keywords":"Escitalopram; Body mass index; CYP2C19; Population; Internal medicine; Volume of distribution; Demography; Medicine; Pharmacokinetics; Antidepressant","retraction":null,"screen_n_in":null,"score":{"opus":0.03755929623619485,"gpt":0.4499459992483756,"spread":0.4123867030121807,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024122,0.0001301434,0.0007086073,0.0000481262,0.00003607462,0.000002712473,0.0001492578,0.0001393798,0.000126517],"category_scores_gemma":[0.0002973535,0.00006262202,0.0001890553,0.00007131761,0.0001785202,0.00004367605,0.00002908265,0.0006568584,0.00001265981],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000161546,"about_ca_system_score_gemma":0.00005216774,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":8.387001e-7,"about_ca_topic_score_gemma":1.398203e-7,"domain_scores_codex":[0.9978401,0.0008293265,0.0008072742,0.0001036649,0.0002699281,0.0001497067],"domain_scores_gemma":[0.9964268,0.00259669,0.0005636617,0.0001480836,0.00008602077,0.0001787318],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1047401,0.003780118,0.06188566,0.0002010014,0.001907818,0.002530736,0.000248387,0.00007169238,0.1670928,0.00007338188,0.05237665,0.6050916],"study_design_scores_gemma":[0.03592264,0.1154772,0.7449047,0.0003903245,0.004188856,0.0009924355,0.0000116132,0.00005861897,0.08785057,0.0005642686,0.009483589,0.0001552195],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9910719,0.002036483,0.00001055262,0.004645617,0.0009584373,0.0002430704,0.000001139589,0.000009668115,0.001023138],"genre_scores_gemma":[0.9953655,0.001930393,0.0001641843,0.001480765,0.0008674557,6.050589e-7,7.106618e-7,0.000009381496,0.0001810104],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.683019,"threshold_uncertainty_score":0.285376,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2095984197","doi":"10.1177/0091270009341182","title":"Acute Hemodynamic Effects of Single‐Dose Sildenafil When Added to Established Bosentan Therapy in Patients With Pulmonary Arterial Hypertension: Results of the COMPASS‐1 Study","year":2009,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta Hospital","funders":"Actelion Pharmaceuticals; Universität Leipzig; Universität zu Köln","keywords":"Sildenafil; Bosentan; Medicine; Pulmonary hypertension; Ambrisentan; Hemodynamics; Internal medicine; Vascular resistance; Cardiology; Pharmacodynamics; Confidence interval; Anesthesia; Pharmacokinetics; Endothelin receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.03882880036594852,"gpt":0.3676106898940989,"spread":0.3287818895281504,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001241363,0.0002110086,0.00117943,0.000172482,0.00005933619,0.000005311821,0.0004569484,0.00009925028,0.00003508325],"category_scores_gemma":[0.0004324226,0.00009465472,0.0002187299,0.0003429569,0.0002286846,0.0001010296,0.00009741959,0.0006240928,0.000002804692],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005610606,"about_ca_system_score_gemma":0.0002340669,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002397236,"about_ca_topic_score_gemma":0.000006625288,"domain_scores_codex":[0.9957103,0.001465445,0.001495045,0.0002134184,0.0007986347,0.0003172202],"domain_scores_gemma":[0.9964159,0.001515538,0.0008042219,0.0003943781,0.0005849396,0.000285086],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4625569,0.07507965,0.1976914,0.00003544195,0.00241538,0.004901976,0.0005260725,0.00007858085,0.2269275,6.657033e-7,0.01088355,0.01890296],"study_design_scores_gemma":[0.0525382,0.03502962,0.9072591,0.0001611047,0.0006129536,0.0001767969,0.00007864436,0.00009941382,0.003820896,0.00005168828,0.00008829362,0.00008327841],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9916545,0.00009354166,0.000001770887,0.00568514,0.0007722708,0.001709427,0.00001409338,0.000005466081,0.00006381128],"genre_scores_gemma":[0.997102,0.0001118283,0.00009284816,0.00240729,0.0002180077,0.000004310818,0.000005092058,0.00001571212,0.00004286728],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7095677,"threshold_uncertainty_score":0.3859907,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2090079955","doi":"10.1177/009127002401102830","title":"Efficacy and Tolerability of Nonprescription Ibuprofen versus Celecoxib for Dental Pain","year":2002,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Ibuprofen; Medicine; Analgesic; Celecoxib; Tolerability; Placebo; Anesthesia; Etodolac; Cancer pain; Adverse effect; Internal medicine; Pharmacology; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.1194450221444662,"gpt":0.43596552186026,"spread":0.3165204997157938,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006140225,0.00008735896,0.0005497859,0.00004262142,0.00004615883,0.000002159448,0.0001098076,0.000117251,0.0002472938],"category_scores_gemma":[0.001851388,0.00005369882,0.0001765403,0.00005023683,0.0002511577,0.00004934115,0.0000281876,0.0004302764,0.000004257327],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002304182,"about_ca_system_score_gemma":0.00004526002,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000174656,"about_ca_topic_score_gemma":0.000001571938,"domain_scores_codex":[0.9977929,0.0008460617,0.0009629435,0.0000845129,0.0001542735,0.0001592864],"domain_scores_gemma":[0.9934718,0.005562882,0.0005368206,0.00009822278,0.0001678882,0.000162389],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1909658,0.005901239,0.126347,0.00115348,0.002244343,0.0001427398,0.001829189,0.0001036734,0.1865145,0.0000703806,0.2151038,0.2696239],"study_design_scores_gemma":[0.2423971,0.07161449,0.4940567,0.0003964459,0.007631719,0.000598073,0.0006780227,0.03422575,0.06919083,0.0004384895,0.07813533,0.0006370032],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944993,0.0005583032,0.0002290021,0.001400522,0.00262489,0.0005970291,0.000002633462,0.000005140252,0.00008316807],"genre_scores_gemma":[0.9969166,0.0004132965,0.0002115544,0.0007799391,0.001619706,0.000005462511,7.372513e-7,0.000009007144,0.00004371234],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3677097,"threshold_uncertainty_score":0.2707694,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2893109079","doi":"10.1002/jcph.1113","title":"Opioids in Breast Milk: Pharmacokinetic Principles and Clinical Implications","year":2018,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Prenatal Substance Exposure Effects","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Oxycodone; Methadone; Breastfeeding; Opioid; Pharmacokinetics; Buprenorphine; Tramadol; Breast milk; Adverse effect; Drug; CYP2D6; Pharmacology; Anesthesia; Pediatrics; Internal medicine; Analgesic","retraction":null,"screen_n_in":null,"score":{"opus":0.1717185619706048,"gpt":0.5239676029081161,"spread":0.3522490409375112,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.01054122,0.0004298761,0.0040052,0.0002634838,0.00006525797,0.00001210875,0.0008082899,0.0006608014,0.000196223],"category_scores_gemma":[0.001293991,0.0002462068,0.001056405,0.0004228397,0.001165473,0.00009159548,0.0003258882,0.003739108,0.00007453999],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000106861,"about_ca_system_score_gemma":0.001145286,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003014186,"about_ca_topic_score_gemma":0.00000472109,"domain_scores_codex":[0.9898294,0.003823433,0.005192682,0.0003937752,0.0003139463,0.0004467949],"domain_scores_gemma":[0.9855205,0.01025976,0.00288087,0.0004390554,0.0003266954,0.0005731265],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001535384,0.001208717,0.005059404,0.00337282,0.001870509,0.0002773752,0.00003334139,8.902271e-7,0.00002194097,0.00002670962,0.03335425,0.9532387],"study_design_scores_gemma":[0.005285712,0.001359034,0.02288165,0.004594842,0.008163517,0.005994082,0.000003842713,0.00002873705,0.000003604425,0.00008185178,0.9513652,0.0002378732],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00942014,0.9817843,0.0000263961,0.003194851,0.00397515,0.001276694,0.00003061603,0.00001865087,0.0002732326],"genre_scores_gemma":[0.003024331,0.9876387,0.0002566958,0.001482697,0.007392404,0.00002034206,0.000008513372,0.00006027818,0.0001160349],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9530008,"threshold_uncertainty_score":0.999999,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2046814818","doi":"10.1177/0091270006288733","title":"Time‐Dependent Interaction Between Lopinavir/Ritonavir and Fexofenadine","year":2006,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; Genome Canada; Ottawa Hospital","funders":"","keywords":"Lopinavir; Ritonavir; Fexofenadine; Lopinavir/ritonavir; Pharmacology; Pharmacokinetics; Medicine; Bioavailability; Chemistry; Internal medicine; Immunology; Viral load; Human immunodeficiency virus (HIV); Coronavirus disease 2019 (COVID-19)","retraction":null,"screen_n_in":null,"score":{"opus":0.07987383447987405,"gpt":0.4649334033480723,"spread":0.3850595688681983,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002477721,0.0001400996,0.0007473562,0.00006676644,0.000106176,0.000007538844,0.0001377466,0.0001206242,0.000330015],"category_scores_gemma":[0.0002671181,0.0000755022,0.0001762755,0.00008707516,0.0004234846,0.0000914394,0.0001038519,0.001027095,0.0000452742],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004048861,"about_ca_system_score_gemma":0.00005567102,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002102751,"about_ca_topic_score_gemma":0.000001928961,"domain_scores_codex":[0.9977848,0.0006188526,0.001030638,0.0001238552,0.000223685,0.0002181599],"domain_scores_gemma":[0.9959293,0.003100196,0.0005599419,0.00007112914,0.0001627597,0.0001766621],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.01931973,0.004340234,0.134726,0.000249372,0.004332902,0.001510032,0.0002091645,0.0004495695,0.2998654,0.00008281271,0.4151924,0.1197224],"study_design_scores_gemma":[0.02072025,0.01079759,0.8075629,0.0001576642,0.005551944,0.00194249,0.0001142839,0.001023619,0.01996461,0.001808813,0.1299775,0.0003782648],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9797104,0.0007754539,0.00008648518,0.01658067,0.001165587,0.0002368385,0.000003977219,0.00001531907,0.001425271],"genre_scores_gemma":[0.9899866,0.0008956807,0.00006742623,0.003511004,0.004892823,0.000001779278,0.000001666603,0.00001027596,0.0006327282],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6728369,"threshold_uncertainty_score":0.4462272,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1987539558","doi":"10.1002/j.1552-4604.2002.tb06009.x","title":"Adolescents Prenatally Exposed to Marijuana: Examination of Facets of Complex Behaviors and Comparisons with the Influence of In Utero Cigarettes","year":2002,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Prenatal Substance Exposure Effects","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Carleton University","funders":"","keywords":"Psychology; Developmental psychology; Context (archaeology); Offspring; Cognition; In utero; Pregnancy; Clinical psychology; Psychiatry; Fetus","retraction":null,"screen_n_in":null,"score":{"opus":0.1170942668625161,"gpt":0.4360151626969021,"spread":0.318920895834386,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003121914,0.0002796755,0.0030038,0.0002478545,0.00002412768,0.000003002383,0.0006334398,0.0002334368,0.00003327333],"category_scores_gemma":[0.0004718523,0.0001428486,0.0002651609,0.000399495,0.0007122767,0.00007796325,0.0001688711,0.001296128,8.384923e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005109132,"about_ca_system_score_gemma":0.0001962599,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008913563,"about_ca_topic_score_gemma":0.00001886354,"domain_scores_codex":[0.9944877,0.001973101,0.002608674,0.0001837848,0.0005278733,0.0002188772],"domain_scores_gemma":[0.9927325,0.002945556,0.003482419,0.0002949311,0.0003890662,0.0001555367],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.006347205,0.004238479,0.02745294,0.02216408,0.002416312,0.000374461,0.002332893,0.0005081455,0.005781226,0.000007607653,0.005927265,0.9224494],"study_design_scores_gemma":[0.009390857,0.007816426,0.9226323,0.03757337,0.007389646,0.0005683177,0.0001256453,0.00006281216,0.001208189,0.000003363301,0.01289149,0.0003375502],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7801617,0.2181696,0.00002782956,0.0001979509,0.0001672088,0.001234838,0.00002426972,0.000003005822,0.00001359472],"genre_scores_gemma":[0.6821414,0.3175109,0.00009071848,0.0001462034,0.00007557271,0.000007365967,0.000003000923,0.00001767812,0.000007215654],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9221118,"threshold_uncertainty_score":0.5825197,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2022326153","doi":"10.1177/0091270003261496","title":"Effect of St. John's Wort on the Pharmacokinetics of Theophylline in Healthy Volunteers","year":2003,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Natural Compound Pharmacology Studies","field":"Agricultural and Biological Sciences","cited_by":62,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Theophylline; Pharmacokinetics; Urine; Crossover study; Hypericum perforatum; Pharmacology; Medicine; Oral administration; Plasma concentration; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.05293921569807965,"gpt":0.4047689388473475,"spread":0.3518297231492679,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01042178,0.0001927528,0.0008464079,0.00003704313,0.0001009945,0.000003243445,0.0007609174,0.0001260339,0.0006949846],"category_scores_gemma":[0.001033647,0.00005125281,0.0003331815,0.0004709144,0.0006669237,0.00004358196,0.00008472761,0.001288285,0.000005703773],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002364325,"about_ca_system_score_gemma":0.00004155663,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001968639,"about_ca_topic_score_gemma":0.00002447706,"domain_scores_codex":[0.9920951,0.005580091,0.001543677,0.0001432768,0.0003318988,0.0003059909],"domain_scores_gemma":[0.9757343,0.02274937,0.001123935,0.00006775051,0.0002271183,0.00009753381],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0746076,0.003363373,0.08775663,0.0001694553,0.002132793,0.0001088405,0.000514397,0.00247951,0.6428865,0.001142533,0.1185306,0.06630778],"study_design_scores_gemma":[0.02777021,0.1064642,0.2622467,0.0002868678,0.002944624,0.0002651394,0.0008881751,0.0007809635,0.3761634,0.004974898,0.2161568,0.001058038],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9848695,0.001401073,8.96456e-7,0.01066866,0.002154006,0.000393389,0.00001307934,0.000004805544,0.0004946373],"genre_scores_gemma":[0.9934322,0.002454991,0.00001456846,0.00346862,0.0005873428,0.000004127152,7.085443e-7,0.000001990833,0.00003547362],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2667231,"threshold_uncertainty_score":0.7609594,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2790919647","doi":"10.1002/jcph.1094","title":"Pharmacokinetics and Tolerability of Letermovir Coadministered With Azole Antifungals (Posaconazole or Voriconazole) in Healthy Subjects","year":2018,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Pharma Medica Research (Canada)","funders":"Merck","keywords":"Posaconazole; Voriconazole; Tolerability; Medicine; Pharmacokinetics; Pharmacology; Azole; Internal medicine; Antifungal; Adverse effect; Dermatology","retraction":null,"screen_n_in":null,"score":{"opus":0.1322770009064881,"gpt":0.4870529437690764,"spread":0.3547759428625883,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004498963,0.0001806312,0.001182336,0.0001894807,0.00007434128,0.000009821013,0.0002959047,0.0001488464,0.0006767018],"category_scores_gemma":[0.0003815167,0.00009736647,0.000122794,0.0003403861,0.001334132,0.00009661761,0.0001270826,0.001123336,0.00001000985],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004542844,"about_ca_system_score_gemma":0.0009329187,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004724918,"about_ca_topic_score_gemma":0.00009467664,"domain_scores_codex":[0.9961658,0.0009056716,0.001881164,0.0002103901,0.0004353833,0.0004016636],"domain_scores_gemma":[0.9955617,0.002391245,0.0008397078,0.0002262365,0.0005906773,0.0003904436],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3707182,0.004395416,0.4285597,0.0006670747,0.0009261426,0.0007604284,0.001517178,0.00001572105,0.1416761,0.00002950523,0.01060566,0.04012896],"study_design_scores_gemma":[0.05465244,0.04842943,0.7603574,0.0003195556,0.00102834,0.001971387,0.0004116464,0.001329266,0.08707558,0.0001616075,0.04389185,0.000371507],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9919144,0.0006524973,0.00003483428,0.005831593,0.0005932613,0.0004995844,0.00001246642,0.000006583095,0.0004547681],"genre_scores_gemma":[0.9919861,0.002246074,0.0002371186,0.004309487,0.001098298,0.000003185157,7.811695e-7,0.00002056216,0.0000983809],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3317977,"threshold_uncertainty_score":0.740941,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2082095891","doi":"10.1002/jcph.235","title":"Abuse potential, pharmacokinetics, pharmacodynamics, and safety of intranasally administered crushed oxycodone HCl abuse‐deterrent controlled‐release tablets in recreational opioid users","year":2013,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Purdue Pharma (Canada)","funders":"Purdue Pharma; Purdue University","keywords":"Oxycodone; Nasal administration; Medicine; Pharmacodynamics; Pharmacokinetics; Pharmacology; Placebo; Tolerability; Opioid; Cmax; Anesthesia; Crossover study; Adverse effect; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.0263692725448008,"gpt":0.366351148035836,"spread":0.3399818754910352,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002218923,0.000378222,0.001848548,0.0003171463,0.00007468645,0.00001941813,0.0004006351,0.0002063654,0.001910827],"category_scores_gemma":[0.0003110477,0.0002561723,0.0004388878,0.0002243312,0.0005736317,0.0002151502,0.00007402097,0.001114662,0.00002316772],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001167764,"about_ca_system_score_gemma":0.0005109675,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008105703,"about_ca_topic_score_gemma":0.00001270008,"domain_scores_codex":[0.9939525,0.001203508,0.003492359,0.0003112008,0.0005608015,0.0004796277],"domain_scores_gemma":[0.9947742,0.002043626,0.001703649,0.0002597063,0.0006668367,0.0005519766],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.3470639,0.02878306,0.1246885,0.001169847,0.01722579,0.001567697,0.008904499,0.006631988,0.3446278,0.00007705861,0.04560292,0.07365701],"study_design_scores_gemma":[0.3972211,0.01045766,0.4950649,0.001082184,0.01302707,0.001075819,0.00142429,0.05823587,0.01127522,0.0004755973,0.009639046,0.001021239],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.986504,0.003409061,0.0002576786,0.005666719,0.002022338,0.001936213,0.00003632335,0.00001671671,0.0001509752],"genre_scores_gemma":[0.94823,0.04713786,0.0007779048,0.002940725,0.0006630415,0.00003363226,0.00002099042,0.00004682126,0.0001489883],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3703764,"threshold_uncertainty_score":0.999989,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1536852940","doi":"10.1002/jcph.491","title":"Population pharmacokinetic analysis of certolizumab pegol in patients with Crohn's disease","year":2015,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"","keywords":"Certolizumab pegol; Pharmacokinetics; Medicine; Population; Volume of distribution; Pharmacodynamics; Internal medicine; Covariate; Pharmacology; Antibody; Gastroenterology; Area under the curve; Immunology; Tumor necrosis factor alpha; Infliximab","retraction":null,"screen_n_in":null,"score":{"opus":0.02767867091703045,"gpt":0.3688769333228261,"spread":0.3411982624057956,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006674427,0.0001163197,0.0003916001,0.0001581962,0.00001925658,0.000003623642,0.0003020905,0.0000725146,0.00006704731],"category_scores_gemma":[0.0003156857,0.00007500757,0.0002090379,0.000237791,0.0001501849,0.000010283,0.00006932909,0.000210943,0.000002077972],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002129984,"about_ca_system_score_gemma":0.0002223197,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007898756,"about_ca_topic_score_gemma":0.00001506585,"domain_scores_codex":[0.9976604,0.0008243248,0.0009504432,0.0001272144,0.00027432,0.000163304],"domain_scores_gemma":[0.9982172,0.0001007349,0.0007919541,0.000181156,0.0004224436,0.0002865176],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02876797,0.0006253103,0.9526268,0.00001193827,0.0009411106,0.0002353732,0.00003560072,0.01410748,0.0003063575,0.000003013834,0.00161805,0.0007210184],"study_design_scores_gemma":[0.006459952,0.0003908948,0.989354,0.00000635903,0.002331662,0.000003791244,0.00001252388,0.0009349426,0.00009892805,0.00002989457,0.0002898512,0.00008724297],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9988713,0.0001081383,0.00007096906,0.0002690459,0.0004236232,0.0001848189,0.00001659203,0.000001875608,0.0000535971],"genre_scores_gemma":[0.9992262,0.00005228617,0.00004286685,0.0003090808,0.0003027829,0.000002403298,0.00002918363,0.00001210102,0.00002309762],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03672717,"threshold_uncertainty_score":0.305872,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2019890777","doi":"10.1002/j.1552-4604.2000.tb05982.x","title":"Drug Labeling and Risk Perceptions of Teratogenicity: A Survey of Pregnant Canadian Women and Their Health Professionals","year":2000,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pregnancy; Health professionals; Perception; Nausea; Vomiting; Risk perception; Family medicine; Drug; Drugs in pregnancy; Obstetrics; Pediatrics; Health care; Psychiatry; Fetus; Psychology; Anesthesia","retraction":null,"screen_n_in":null,"score":{"opus":0.06532141854844371,"gpt":0.4494132688665164,"spread":0.3840918503180727,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007273782,0.00007844082,0.0006136147,0.00008657864,0.00008746764,0.000001524124,0.0001024441,0.00006773009,0.0006397953],"category_scores_gemma":[0.0006505791,0.00004195115,0.00005734749,0.0001044669,0.0003123011,0.00004548367,0.00001871018,0.0005425702,0.000001103322],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003173167,"about_ca_system_score_gemma":0.001498559,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003300189,"about_ca_topic_score_gemma":0.001891305,"domain_scores_codex":[0.9969167,0.001622054,0.001065217,0.00007635156,0.0001201477,0.0001995641],"domain_scores_gemma":[0.9967158,0.001735706,0.0006996153,0.0001006217,0.0001956813,0.000552596],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00405272,0.001200222,0.6882321,0.000285671,0.00131512,0.00001128289,0.02781168,0.00002644109,0.002917978,0.00000572397,0.01719405,0.256947],"study_design_scores_gemma":[0.004001255,0.001181621,0.9908384,0.0006472066,0.0001785918,0.000184922,0.0009720906,0.000187793,0.0003128724,0.0001477578,0.001290491,0.00005697051],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892217,0.004431006,0.00001100689,0.005793784,0.0001885174,0.0002339492,0.00007215736,0.000002118456,0.00004577701],"genre_scores_gemma":[0.9663703,0.03038613,0.00006390159,0.002916536,0.0001170434,0.000002102794,0.000001942336,0.000006224143,0.000135804],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3026063,"threshold_uncertainty_score":0.700531,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2079912339","doi":"10.1177/00912700122010735","title":"The Safety of Higher Than Standard Dose of Doxylamine‐Pyridoxine (Diclectin®) for Nausea and Vomiting of Pregnancy","year":2001,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Nausea; Vomiting; Pregnancy; Adverse effect; Incidence (geometry); Metoclopramide; Antiemetic; Birth weight; Obstetrics; Gestational age; Population; Hyperemesis gravidarum; Anesthesia; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.08021228769728539,"gpt":0.4714493809293559,"spread":0.3912370932320705,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004211422,0.0001043924,0.0007607984,0.00005987302,0.0000745843,0.000001624005,0.0002274333,0.0001141188,0.0001133112],"category_scores_gemma":[0.002125709,0.00005208183,0.0002337545,0.0001451007,0.000723757,0.00006073103,0.00003970761,0.0004698553,2.882178e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001819775,"about_ca_system_score_gemma":0.0003017545,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003455509,"about_ca_topic_score_gemma":0.000002485291,"domain_scores_codex":[0.9971561,0.000417395,0.001845232,0.00008594801,0.0002907513,0.0002045664],"domain_scores_gemma":[0.9911478,0.006045795,0.001946259,0.000177578,0.0005214085,0.0001611311],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1831558,0.002900564,0.1728082,0.00157189,0.005273912,0.00008825002,0.002718861,0.00008621054,0.2114572,0.001057437,0.03071234,0.3881693],"study_design_scores_gemma":[0.07128286,0.01865852,0.6550939,0.0043252,0.00481864,0.0009624724,0.000563462,0.0003804255,0.1792529,0.003179983,0.06120747,0.0002741485],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9805074,0.008206232,0.0006965423,0.008342671,0.0009807543,0.0004913393,0.00001890841,0.000004921424,0.0007511798],"genre_scores_gemma":[0.9866549,0.01166321,0.0002502109,0.0004038798,0.0005697579,0.000003045966,7.844301e-7,0.000012157,0.0004420453],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4822857,"threshold_uncertainty_score":0.2666713,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1972752819","doi":"10.1177/009127002401102803","title":"Pharmacokinetics of GW433908, a Prodrug of Amprenavir, in Healthy Male Volunteers","year":2002,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Smiths Detection (Canada)","funders":"","keywords":"Amprenavir; Pharmacokinetics; Bioequivalence; Pharmacology; Prodrug; Bioavailability; Crossover study; Medicine; Chemistry; Protease; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.08639558196707112,"gpt":0.4306749514898969,"spread":0.3442793695228258,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002375116,0.000141058,0.000909756,0.0001860822,0.00002154972,0.000001383946,0.0002618667,0.00009945404,0.001600465],"category_scores_gemma":[0.0002019038,0.00008726032,0.0002085487,0.0002498639,0.0003054168,0.00007218281,0.00004773561,0.0006844676,0.00002052551],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004467115,"about_ca_system_score_gemma":0.0001910822,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009356691,"about_ca_topic_score_gemma":0.000005577458,"domain_scores_codex":[0.9965114,0.0006328293,0.002151617,0.0001218575,0.0003379755,0.0002442971],"domain_scores_gemma":[0.9976135,0.000829324,0.0009057249,0.0001572664,0.0002714038,0.0002227376],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04149112,0.02670606,0.6088344,0.0007185245,0.003193168,0.000964315,0.008820977,0.0009777665,0.04348002,0.00005642697,0.2018743,0.06288288],"study_design_scores_gemma":[0.2375889,0.04587962,0.3575317,0.001500879,0.01163007,0.004332229,0.002375368,0.03024467,0.1104286,0.0006654717,0.1966203,0.001202207],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9861717,0.001232222,0.00002065348,0.01059243,0.0008034664,0.0003690542,0.000006773098,0.000004865046,0.0007988485],"genre_scores_gemma":[0.9915954,0.004065497,0.0009005509,0.00134364,0.0004162936,0.000003406034,0.00000162897,0.00001549549,0.001658119],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2513028,"threshold_uncertainty_score":0.9993122,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2037845030","doi":"10.1177/0091270005280851","title":"Effect of a Triphasic Oral Contraceptive on Drug‐Metabolizing Enzyme Activity as Measured by the Validated Cooperstown 5+1 Cocktail","year":2005,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":59,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Pharmacology; CYP2C19; Dextromethorphan; Medicine; CYP3A; CYP1A2; Drug; CYP2C9; Bioequivalence; Pharmacokinetics; Crossover study; Drug metabolism; Dextrorphan; Mephenytoin; Paraxanthine; Active metabolite; Oral administration; Internal medicine; Cytochrome P450; Metabolism; Placebo","retraction":null,"screen_n_in":null,"score":{"opus":0.1423813856677076,"gpt":0.5159168353209036,"spread":0.373535449653196,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.02517587,0.000546935,0.001836184,0.000170347,0.0004496689,0.00002216637,0.001553309,0.0004857724,0.00221988],"category_scores_gemma":[0.001592626,0.0003005839,0.0008108456,0.0004869397,0.001443174,0.00020121,0.0001890308,0.004313666,0.0001654668],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000809085,"about_ca_system_score_gemma":0.0004267223,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002617079,"about_ca_topic_score_gemma":0.000006140699,"domain_scores_codex":[0.9763479,0.01963989,0.00216508,0.0003559946,0.0006992768,0.0007918312],"domain_scores_gemma":[0.9799019,0.01615668,0.00239179,0.0003474744,0.0006275057,0.0005746323],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.04117741,0.001979017,0.0003349098,0.00002883581,0.002413534,0.0000391843,0.0008155364,0.003511677,0.60115,0.00006587391,0.1600996,0.1883844],"study_design_scores_gemma":[0.01642486,0.001869752,0.000287568,0.00001502309,0.003161802,0.0001128457,0.00005790158,0.001708351,0.6183584,0.0000490542,0.3577215,0.0002328821],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9738362,0.007285194,0.0001327028,0.00951816,0.006535164,0.001046217,0.0000944454,0.00003265966,0.001519268],"genre_scores_gemma":[0.9804118,0.00472597,0.0000292701,0.01141834,0.002618098,0.00002476007,0.000003564891,0.00005291233,0.0007153039],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1976219,"threshold_uncertainty_score":0.9999446,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2153400265","doi":"10.1177/0091270011405524","title":"Pregnancy Outcomes Following Use of Escitalopram: A Prospective Comparative Cohort Study","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Escitalopram; Medicine; Prospective cohort study; Pregnancy; Cohort study; Cohort; Obstetrics; Internal medicine; Psychiatry; Anxiety; Antidepressant","retraction":null,"screen_n_in":null,"score":{"opus":0.2805889978629389,"gpt":0.4991210865169983,"spread":0.2185320886540594,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001991005,0.0001541253,0.001182966,0.00007626748,0.00006876598,0.000003493437,0.0002266177,0.00007750402,0.0002343202],"category_scores_gemma":[0.0002472383,0.00008547011,0.0003377114,0.00010636,0.0002032711,0.0001695621,0.00008249541,0.0007302822,0.00001849961],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003279581,"about_ca_system_score_gemma":0.0001476742,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004911542,"about_ca_topic_score_gemma":0.000006265355,"domain_scores_codex":[0.996649,0.0009163914,0.001726073,0.000135566,0.0003471546,0.0002258756],"domain_scores_gemma":[0.9967307,0.001476245,0.001162193,0.0001852824,0.0002425539,0.0002030373],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003735807,0.002945479,0.9872509,0.000120301,0.001515935,0.0002332649,0.003847957,0.000002881196,0.00006369173,0.00001760024,0.0001409348,0.0001252086],"study_design_scores_gemma":[0.005114124,0.005844129,0.9836737,0.000789203,0.001415163,0.00006446685,0.0003438998,0.000009746993,0.002489506,0.000143575,0.00004078068,0.00007173936],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946094,0.000409776,0.00002861086,0.0002043158,0.002729214,0.001438625,0.000003455023,0.00001031192,0.0005662628],"genre_scores_gemma":[0.9984739,0.0001303486,0.0003349962,0.0005360245,0.0001198855,0.00001022506,3.003555e-7,0.00001202921,0.0003822513],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003864511,"threshold_uncertainty_score":0.348537,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2280682835","doi":"10.1002/jcph.714","title":"Effect of Renal and Hepatic Impairment on the Pharmacokinetics of Cabozantinib","year":2016,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Celerion (Canada)","funders":"Exelixis","keywords":"Cabozantinib; Pharmacokinetics; Medicine; Tyrosine-kinase inhibitor; Internal medicine; Adverse effect; Renal function; Gastroenterology; Dosing; Body mass index; Toxicity; Urology; Oncology; Cancer; Pharmacology","retraction":null,"screen_n_in":null,"score":{"opus":0.06468027082223873,"gpt":0.4890645115591757,"spread":0.4243842407369369,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009930084,0.0001130564,0.0009667566,0.00007380556,0.00003938029,0.00000112183,0.0002383614,0.00009425452,0.000647497],"category_scores_gemma":[0.001764336,0.00003814513,0.0002011311,0.00009248527,0.001076906,0.0000207525,0.00007935729,0.0005280168,0.000007907399],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001722089,"about_ca_system_score_gemma":0.0002281564,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000467609,"about_ca_topic_score_gemma":4.168654e-7,"domain_scores_codex":[0.995713,0.002391856,0.00124235,0.00008597371,0.0003632519,0.0002035928],"domain_scores_gemma":[0.9765437,0.02203824,0.0008618043,0.0001632524,0.0002350916,0.0001579544],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.07841066,0.002113791,0.4254188,0.0004372978,0.003611556,0.0001880595,0.0004284308,0.00001201844,0.3797252,0.000188001,0.04746002,0.06200612],"study_design_scores_gemma":[0.06747324,0.1244879,0.3588669,0.001177567,0.01086404,0.001163877,0.00009883956,0.001291339,0.4234549,0.0006997877,0.01019046,0.0002311443],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9847115,0.0003518144,0.00007575444,0.013383,0.0004135157,0.0004307793,0.000004670656,0.000002451406,0.0006265152],"genre_scores_gemma":[0.9939449,0.004253501,0.00004730242,0.0009900719,0.0005326113,0.000003866389,1.228391e-7,0.000009037817,0.0002186031],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1223741,"threshold_uncertainty_score":0.7089638,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2056298376","doi":"10.1177/0091270004273320","title":"CYP3A and P‐Glycoprotein Activity Induction With St. John's Wort in Healthy Volunteers From 6 Ethnic Populations","year":2005,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Clinical pharmacology; Family medicine; Library science; Traditional medicine; Pharmacology","retraction":null,"screen_n_in":null,"score":{"opus":0.1115504981406245,"gpt":0.4478634263768943,"spread":0.3363129282362698,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00174112,0.0001080024,0.0005079511,0.0001029358,0.00005830283,0.000003092387,0.00009382008,0.0001461445,0.0002299244],"category_scores_gemma":[0.0000518856,0.00006255056,0.00008350424,0.0001755292,0.0001818946,0.0001311503,0.00001257616,0.00124122,0.000004014453],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005950457,"about_ca_system_score_gemma":0.0002181788,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001036131,"about_ca_topic_score_gemma":0.0009559876,"domain_scores_codex":[0.9983881,0.0003340573,0.0007367528,0.0001277341,0.0002237589,0.0001895716],"domain_scores_gemma":[0.9989445,0.000275843,0.0003984015,0.0001022976,0.00009054629,0.0001884463],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.2157391,0.006646001,0.2224781,0.0001807054,0.001630719,0.0007908233,0.003260451,0.003600754,0.09304678,0.0001855445,0.009393385,0.4430476],"study_design_scores_gemma":[0.01161342,0.002392651,0.9752715,0.0001290261,0.000683887,0.0001678524,0.0002364375,0.0005427288,0.001514999,0.0004194633,0.006899104,0.0001288931],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9734172,0.000629111,0.0008385941,0.02393222,0.0008019118,0.0002860944,0.000003951538,0.000009002979,0.00008190837],"genre_scores_gemma":[0.9939267,0.001252461,0.001415662,0.00195639,0.001322043,0.000003176308,0.000002289331,0.00001283358,0.0001084213],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7527934,"threshold_uncertainty_score":0.5392553,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1603001808","doi":"10.1002/jcph.247","title":"Pharmacokinetic characterization of baclofen in patients with chronic kidney disease: dose adjustment recommendations","year":2014,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Maisonneuve-Rosemont; McGill University Health Centre; Université de Montréal; inVentiv Health Clinical","funders":"","keywords":"Renal function; Pharmacokinetics; Kidney disease; Cmax; Medicine; Urology; Creatinine; Baclofen; Internal medicine; Pharmacology; Agonist","retraction":null,"screen_n_in":null,"score":{"opus":0.02620408836226334,"gpt":0.3602540680354392,"spread":0.3340499796731759,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008998589,0.0001132958,0.0004569386,0.00009057715,0.00002811385,0.000001767387,0.0001690073,0.00009132853,0.0008721768],"category_scores_gemma":[0.0002560533,0.00006020087,0.0001201495,0.0001902814,0.0002083011,0.00006070433,0.00003796397,0.0007213386,0.0000103507],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002785554,"about_ca_system_score_gemma":0.0001852505,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":8.763193e-7,"about_ca_topic_score_gemma":3.605554e-7,"domain_scores_codex":[0.9976239,0.0008161828,0.00106208,0.000112352,0.0002119493,0.0001734861],"domain_scores_gemma":[0.9981813,0.0005118233,0.0007175767,0.0001163625,0.0001698992,0.0003030139],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.08802191,0.01862732,0.5998668,0.0004650167,0.001865763,0.00006342702,0.0002910307,0.001850692,0.05622239,0.0001107239,0.0352618,0.1973532],"study_design_scores_gemma":[0.01834621,0.003716436,0.9588817,0.00009833939,0.0007570404,0.000005835425,0.000002397178,0.001170357,0.0002463639,0.00006081933,0.01664451,0.00006995664],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9755411,0.0001016815,0.0001306154,0.02247033,0.001195173,0.0004094175,0.000008508946,0.000006922233,0.0001362212],"genre_scores_gemma":[0.9879552,0.002645241,0.00003950267,0.008828868,0.0004238609,0.000003722618,0.00002395281,0.00001285778,0.00006678669],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.359015,"threshold_uncertainty_score":0.9549725,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2002629531","doi":"10.1177/0091270006288953","title":"Pharmacokinetics and Urinary Excretion of Vincristine Sulfate Liposomes Injection in Metastatic Melanoma Patients","year":2006,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Advancements in Transdermal Drug Delivery","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":52,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Inimex Pharmaceuticals (Canada)","funders":"","keywords":"Pharmacokinetics; Vincristine; Chemistry; Volume of distribution; Pharmacology; Urology; Distribution (mathematics); Medicine; Chemotherapy; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1048697138698532,"gpt":0.4804081156616854,"spread":0.3755384017918322,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003648148,0.0002333361,0.0007218087,0.0002462067,0.00009788955,0.000004559834,0.0003616239,0.0001932886,0.0004919682],"category_scores_gemma":[0.0002138478,0.000176077,0.0001549155,0.0002690896,0.0007128399,0.0002075844,0.0001130544,0.001504666,0.000008763835],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005371869,"about_ca_system_score_gemma":0.0000905323,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003307548,"about_ca_topic_score_gemma":0.000007599499,"domain_scores_codex":[0.9941143,0.002783587,0.002284371,0.0001903322,0.0002759183,0.0003515155],"domain_scores_gemma":[0.995019,0.003004959,0.001388922,0.0001068892,0.0003377409,0.000142453],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03755516,0.01362646,0.6829901,0.0005396789,0.001858443,0.0004895398,0.000921162,0.06400999,0.09544492,0.0002657518,0.02146761,0.08083123],"study_design_scores_gemma":[0.06082762,0.0111589,0.7491772,0.0001469885,0.005435632,0.000795917,0.0003248764,0.01536329,0.0633835,0.005442889,0.08701532,0.0009278471],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922645,0.001814378,0.0007866512,0.0008429174,0.003507728,0.0004027449,0.0000328324,0.00001177666,0.0003364768],"genre_scores_gemma":[0.9944249,0.003339152,0.0003786258,0.00101329,0.0007016975,0.00000627496,0.000009219338,0.00002314205,0.0001036963],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07990338,"threshold_uncertainty_score":0.7180211,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2162908443","doi":"10.1177/0091270007308615","title":"Assessment of Pharmacokinetics and Pharmacodynamic Effects Related to Abuse Potential of a Unique Oral Osmotic‐Controlled Extended‐Release Methylphenidate Formulation in Humans","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Methylphenidate; Placebo; Stimulant; Crossover study; Pharmacodynamics; Pharmacokinetics; Pharmacology; Anesthesia; Controlled release; Medicine; Attention deficit hyperactivity disorder; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.03448215947735757,"gpt":0.4752178458980692,"spread":0.4407356864207116,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00774322,0.0002037297,0.001397818,0.0004529466,0.00003811424,0.000003813884,0.0001938739,0.0001719905,0.0001920674],"category_scores_gemma":[0.0005719549,0.0001439612,0.0003334252,0.0003780502,0.0001907699,0.0001447622,0.00006861955,0.001123613,0.000001623223],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006346982,"about_ca_system_score_gemma":0.0001915771,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001475659,"about_ca_topic_score_gemma":0.000008585008,"domain_scores_codex":[0.995027,0.001373552,0.002668086,0.0001802797,0.0004510524,0.0003000326],"domain_scores_gemma":[0.9944559,0.002991751,0.001623362,0.0001556154,0.000513524,0.0002599002],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0248877,0.003742247,0.03872112,0.0002379734,0.001491835,0.0003145793,0.0004580774,0.008842551,0.9080694,0.0001086036,0.0001198927,0.01300601],"study_design_scores_gemma":[0.08505164,0.003859726,0.8513093,0.0001803994,0.004935091,0.0002232554,0.0003004864,0.04192168,0.0115045,0.0003881349,0.000113634,0.0002121577],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9864072,0.0002361389,0.01004734,0.001160936,0.0008418382,0.001186758,0.000003921584,0.000009500538,0.0001064021],"genre_scores_gemma":[0.9967123,0.000708481,0.001561201,0.0007967874,0.0001294277,0.000004266363,0.000003027942,0.00002700112,0.00005754015],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8965649,"threshold_uncertainty_score":0.5870569,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1983440297","doi":"10.1177/0091270010395940","title":"Anti‐EGFR Monoclonal Antibodies for Treatment of Colorectal Cancers: Development of Cetuximab and Panitumumab","year":2011,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Panitumumab; Cetuximab; Medicine; Bevacizumab; Colorectal cancer; Epidermal growth factor receptor; Monoclonal antibody; Clinical trial; Oncology; Internal medicine; Adjuvant; EGFR inhibitors; Pharmacology; Cancer; Antibody; Immunology; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.2655273053984388,"gpt":0.5152066995027675,"spread":0.2496793941043287,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009537066,0.0003732083,0.0050139,0.0001503477,0.00009266914,0.000002576355,0.0001833759,0.0002155063,0.00008032387],"category_scores_gemma":[0.000115678,0.0001856267,0.0008881287,0.0001067307,0.0005934453,0.0000331162,0.0000821047,0.0002411188,0.00000108139],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002726624,"about_ca_system_score_gemma":0.002152059,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000270956,"about_ca_topic_score_gemma":0.00002515267,"domain_scores_codex":[0.996384,0.000306263,0.002662598,0.0002016769,0.0001871374,0.0002582714],"domain_scores_gemma":[0.9945728,0.002042879,0.00269817,0.0001180825,0.0004265862,0.000141532],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.006121636,0.001521255,0.0007255712,0.00439114,0.01000932,0.00003086509,0.001037149,4.610513e-7,0.00002859215,0.00001003057,0.0009304802,0.9751935],"study_design_scores_gemma":[0.01132822,0.01698131,0.003230496,0.002360679,0.02359715,0.0004044849,0.0001783304,0.000005984583,0.0005145079,0.00003947837,0.9411269,0.0002324113],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.08563915,0.9116793,0.00001182053,0.00008293792,0.001169494,0.00114484,0.00007273456,0.000004059679,0.00019568],"genre_scores_gemma":[0.01340281,0.9843917,0.001451004,0.000040868,0.0005389174,0.00004937388,0.000007972637,0.00002849069,0.00008886989],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9749611,"threshold_uncertainty_score":0.7569636,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2009236753","doi":"10.1177/00912700222011418","title":"Limited Sampling Strategy to Predict AUC of the CYP3A Phenotyping Probe Midazolam in Adults: Application to Various Assay Techniques","year":2002,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences North","funders":"","keywords":"Midazolam; Reproducibility; Mean squared error; CYP3A; Sampling (signal processing); Linear regression; Pharmacokinetics; Mathematics; Statistics; Medicine; Anesthesia; Pharmacology; Internal medicine; Computer science","retraction":null,"screen_n_in":null,"score":{"opus":0.1744647049555976,"gpt":0.4897639880220149,"spread":0.3152992830664174,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008267464,0.0003099772,0.0008588581,0.0002808952,0.0001876083,0.00001295751,0.001525263,0.0004276608,0.0004751277],"category_scores_gemma":[0.0008242535,0.0002027287,0.0003070231,0.0008653438,0.0003008307,0.0001041978,0.0003434064,0.00245732,0.00004292887],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007765539,"about_ca_system_score_gemma":0.0001722153,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002137498,"about_ca_topic_score_gemma":0.00002020356,"domain_scores_codex":[0.9931392,0.003026195,0.002533354,0.0003239664,0.00038089,0.0005963799],"domain_scores_gemma":[0.9947375,0.002672703,0.00129713,0.0003399714,0.0004927453,0.0004599351],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.006333851,0.003161665,0.0173639,0.0001405296,0.0007200886,0.00002735272,0.003213628,0.03128736,0.4175228,0.0003151491,0.01927873,0.5006349],"study_design_scores_gemma":[0.01504076,0.003194493,0.06219219,0.000434005,0.002595912,0.0002582813,0.000431773,0.05525211,0.2953095,0.003455552,0.560674,0.001161499],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9741597,0.001432383,0.008176035,0.009089692,0.003543768,0.002078036,0.00004388051,0.00004462004,0.001431929],"genre_scores_gemma":[0.9827401,0.001824269,0.001486164,0.01203371,0.001728855,0.00005825935,0.000001348027,0.00003874234,0.00008854621],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5413952,"threshold_uncertainty_score":0.9998441,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2153778965","doi":"10.1002/jcph.570","title":"Pharmacokinetics and pharmacodynamics of a human monoclonal anti‐FGF23 antibody (KRN23) in the first multiple ascending‐dose trial treating adults with X‐linked hypophosphatemia","year":2015,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Shriners Hospitals for Children - Canada","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Kyowa Hakko Kirin; University of California, San Francisco; Shriners Hospitals for Children; Yale University","keywords":"Pharmacokinetics; Pharmacodynamics; Hypophosphatemia; Medicine; Pharmacology; Monoclonal antibody; Antibody; Internal medicine; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.08344190394491893,"gpt":0.4537382079247536,"spread":0.3702963039798347,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002969959,0.0002691965,0.001024581,0.0001380062,0.0001172365,0.00001283663,0.0003528544,0.0001364237,0.00001711022],"category_scores_gemma":[0.0003209642,0.0001370031,0.0001985456,0.0002930158,0.0004696327,0.0001145335,0.00007321904,0.0009564795,0.000002768855],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004599594,"about_ca_system_score_gemma":0.000265205,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007699995,"about_ca_topic_score_gemma":0.00002610609,"domain_scores_codex":[0.9966432,0.0006548568,0.00166784,0.0002112075,0.0004810416,0.000341833],"domain_scores_gemma":[0.9961916,0.001792185,0.001294913,0.0001767339,0.000282589,0.0002620221],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3512925,0.009421346,0.6031581,0.00009553461,0.001846816,0.00124446,0.004629317,0.0009352021,0.01425559,0.00001733441,0.01018761,0.002916175],"study_design_scores_gemma":[0.7301775,0.02127841,0.2182968,0.0002128959,0.004192047,0.001047617,0.002044854,0.01813401,0.0021862,0.0001465161,0.001909296,0.0003738585],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937773,0.002533734,0.00002242228,0.001738671,0.0006653173,0.0009957791,0.00001269788,0.000009091902,0.0002449925],"genre_scores_gemma":[0.9957303,0.002313631,0.0002304131,0.0008923342,0.000759907,0.00001053202,0.00001070287,0.00002671578,0.00002543419],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3848614,"threshold_uncertainty_score":0.5586824,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2092729209","doi":"10.1177/0091270007306957","title":"Pharmacokinetic Profile of Temsirolimus With Concomitant Administration of Cytochrome P450‐Inducing Medications<sup>1</sup>","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Temsirolimus; Pharmacology; Sirolimus; CYP3A4; Pharmacokinetics; CYP3A; Concomitant; Medicine; Cytochrome P450; Internal medicine; Chemistry; Discovery and development of mTOR inhibitors; PI3K/AKT/mTOR pathway; Biochemistry; Metabolism","retraction":null,"screen_n_in":null,"score":{"opus":0.03752277635510766,"gpt":0.4024501635515368,"spread":0.3649273871964292,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003089191,0.0001248311,0.0004202883,0.00006289186,0.00004033359,0.000002647086,0.0003476925,0.0001439477,0.0001274357],"category_scores_gemma":[0.00008044672,0.0000811953,0.0001481394,0.0001192615,0.0003402354,0.000006151963,0.00004884091,0.0003255306,0.000001194841],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001352374,"about_ca_system_score_gemma":0.0004730362,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000459095,"about_ca_topic_score_gemma":0.000003814571,"domain_scores_codex":[0.9978424,0.0002634244,0.001312466,0.0001317759,0.0002524751,0.0001974615],"domain_scores_gemma":[0.9976014,0.000359506,0.001312099,0.0001840075,0.0004081279,0.0001348547],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0051512,0.000333174,0.0001967104,0.00003062684,0.000515434,0.00001281796,0.0001191487,0.0003542095,0.9864183,0.00005329046,0.000792114,0.006022984],"study_design_scores_gemma":[0.004785538,0.005878036,0.004746932,0.00004257401,0.0007099598,0.0003106357,0.0002435133,0.0004633309,0.972598,0.0001171413,0.009977727,0.0001265873],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923104,0.0006285898,0.005363012,0.0006558502,0.0003183566,0.0002588506,0.0000140754,0.000002530176,0.0004483293],"genre_scores_gemma":[0.996453,0.0009344034,0.000751679,0.0007309188,0.001019732,0.00000329207,0.000006156964,0.00001644248,0.00008436357],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01382027,"threshold_uncertainty_score":0.3311048,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1978188503","doi":"10.1177/0091270011399577","title":"Opioid Receptor Modulation of Hedonic Taste Preference and Food Intake: A Single‐Dose Safety, Pharmacokinetic, and Pharmacodynamic Investigation With GSK1521498, a Novel μ‐Opioid Receptor Inverse Agonist","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Neuropeptides and Animal Physiology","field":"Neuroscience","cited_by":49,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Discovery Centre","funders":"","keywords":"Overeating; Inverse agonist; Pharmacokinetics; Pharmacodynamics; Pharmacology; Endogenous opioid; Opioid; Agonist; Taste; Opioid receptor; Medicine; Receptor; Endocrinology; Chemistry; Internal medicine; Obesity; Food science","retraction":null,"screen_n_in":null,"score":{"opus":0.1585381157846783,"gpt":0.3344828411170219,"spread":0.1759447253323436,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001000284,0.0002818929,0.0006570571,0.00012988,0.0001543452,0.00001720192,0.000458516,0.0001155128,0.0002230129],"category_scores_gemma":[0.0003516031,0.0001889775,0.0001042495,0.000277142,0.001559172,0.0003880798,0.0002409459,0.0008690006,0.000008790163],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003004451,"about_ca_system_score_gemma":0.0001867173,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001224794,"about_ca_topic_score_gemma":0.000007785332,"domain_scores_codex":[0.9965711,0.00102369,0.001406321,0.0003880204,0.000279535,0.0003313081],"domain_scores_gemma":[0.9964191,0.001244932,0.001657593,0.0001592073,0.0002142331,0.0003048932],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.005973464,0.0004492833,0.0008105511,0.00006889196,0.00008508618,0.000005231329,0.0006077091,0.0001009411,0.9842398,0.0001362705,0.0004295806,0.007093199],"study_design_scores_gemma":[0.0192525,0.02198642,0.04412676,0.000267696,0.0009474512,0.0005209349,0.0002198622,0.008466133,0.893086,0.001937381,0.008486076,0.0007028511],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975913,0.0001263281,0.0001363443,0.0004563519,0.0009667207,0.0004593152,0.00004330821,0.00002023009,0.0002001038],"genre_scores_gemma":[0.9927807,0.003530281,0.0009523699,0.002223769,0.0004274859,0.000005863401,0.000002348722,0.00003453824,0.00004259056],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09115385,"threshold_uncertainty_score":0.7706277,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}